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Abstract
The correct and timely delivery of immune cells is critical for protection against
foreign antigen. In order for cells to access most organs, there are requirements that
must be met to facilitate exit from the blood into extravasculature. The initial
requirement is selectin-selectin ligand interactions that mediate tethering and rolling to
allow shear resistance. For proper selectin-selectin ligand interaction, glycoproteins
must be modified by fucosyltransferases –IV and –VII, which adds fucose to an
acceptor substrate to form the sialyl-LewisX moiety. Using fucosyltransferase –IV and –
VII double knockout (FtDKO) mice, we made several novel observations. Our first
observation showed increased numbers of naïve T cells in non-lymphoid organs. To
support this observation, we blocked chemokine-mediated entry into lymph nodes (LNs)
with pertussis toxin and L-selectin mediated entry with anti-CD62L antibody in WT mice.
We also treated WT mice with the S1P1 agonist, FTY720, to retain lymphocytes in LNs.
Our results suggested that when access to LN is perturbed, lymphocytes accumulate in
non-lymphoid organs. Our second observation showed an enrichment of
effector/memory T cells in FtDKO LNs. To determine if effector/memory CD8 T cells
were retained in LNs, we transferred naïve and memory CD8 T cells into WT mice then
treated the recipient mice with anti-CD62L. We found that LN exit rates of naïve and
memory CD8 T cells were similar, but slowed as T cell density decreased. To
understand if memory CD8 T cells were using selectin ligand independent mechanisms,
we transferred naïve and memory CD8 T cells into WT or FtDKO mice. We found
iii

reduced numbers of memory CD8 T cells in LNs, however, their frequency was
increased. We explored this result by transferring CFSE labeled memory CD8 T cells.
We found that memory CD8 T cells divide more in FtDKO mice compared to WT. These
experiments suggested that selectin ligand deficiencies cause increased frequency of
effector/memory T cells in LNs due to low density and increased emptiness induced
proliferation. Taken together, these findings reveal how selectin ligand deficiencies
contribute to T cell accumulation in non-lymphoid organs and elucidate mechanisms of
retention in LNs.
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Chapter 1
Introduction and Literature Review

Introduction
Seminal research conducted by Gowns and colleagues in rats during the early
1960’s has paved the way for understanding the importance of cell migration in
immunity [1,2]. Concurrent with these observations, Morris was conducting studies in
sheep where he and colleagues identified distinct recirculation processes involving the
movement of lymphocytes from the blood to lymph nodes via afferent lymphatics [3].
Furthermore, using the ovine model, surgical procedures allowing access to the
lymphatic vessels that drained lymph nodes made examining the recirculation of
intravenously injected cells through lymph nodes over extended periods of time
extremely informative [4,5]. The knowledge gained during these pioneering studies has
contributed immensely to the current experimental designs that seek to elucidate the
mechanisms associated with leukocyte migration to tissues and organs.
Lymphocytes play an integral role in providing the necessary protection against
foreign antigen. Since these cells respond to antigen through direct contact, their
migration to sites where the antigen can be found is essential [6]. This process of cell
delivery, which has been actively studied in vitro and confirmed in vivo, begins with
tethering or capture, followed by rolling, arrest, crawling, and extravasation (Figure 1.1)
[7,8]. The ability for cells to employ these steps and be delivered to the precise organ
relies heavily on the expression of various proteins found on the surface of both the
adherent cell and the endothelial cell [9]. During an immune response, inflammatory
mediators induce changes to endothelium and leukocytes, such that those changes
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facilitate entry into peripheral organs at greater frequency [10]. With this greater
frequency of trafficking, responses can be initiated and antigens cleared.
Understanding the mechanisms that contribute to the delivery of cells during
homeostasis or inflammation may provide us with additional insight into therapeutic or
diagnostic strategies that could prevent or curtail the effects of misguided trafficking.

Cellular Adhesion

Very specialized vascular endothelium controls the movement of cells from blood
into adjacent organs. Typically, cells that migrate to extravascular sites use post
capillary venues, but may also be subject to capillary diameter restrictions that allow
entry into various organs (i.e. lung) [11,12,13]. During the short time leukocytes are in
the blood, blood flow moves leukocytes around rapidly [9]. As a consequence, shear
forces move cells through the vasculature at high rates and only those cells with proper
attachment can adhere to the vascular endothelium. To achieve proper attachment,
leukocytes must employ adhesion molecules to form stable interactions with the
vascular wall leading to entry of specific cells while excluding others [14,15]. One
location where this specific process occurs frequently is at the lymph node where
specialized endothelial cells make up the high endothelial venue. The high endothelial
venue supports the trafficking of cells that contain the necessary adhesion molecules
that allows attachment to this location. However, endothelial cells in other locations that
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experience inflammatory mediators (i.e. TNFa, IFNg, and IL-1) can also upregulate the
necessary adhesion molecules that allow migration to locations where in the steady
state, cellular access is less likely to occur [16].

Selectins
In order to reach extravascular organs, leukocytes must interact with several
adhesion molecules. The first and most important step for successful exit from the
vasculature is initial tethering and rolling which is facilitated by selectins. Selectins are
c-type lectins expressed on leukocytes (L- selectin), endothelial cells (E- and Pselectins) and activated platelets (P-selectin) [17]. To achieve the stable interactions
necessary for resistance to shear forces, selectins must interact with selectin ligands
rapidly, with high tensile strength, and with quick dissociation rates [18,19]. These
requirements are achieved due to binding of selectin with sialyl-LewisX containing
glycoproteins.
L-selectin, is expressed by all myeloid cells, naïve T cells, and central memory T
cells. P-selectin is constitutively expressed on lung endothelium and found on the
surface of activated platelets and inflamed endothelial cells. E-selectin is expressed on
inflamed endothelial cells and non-inflamed skin vasculature [6]. The respective ligands
for these selectins are carbohydrate-containing structures that must be modified by
specific glycosyltransferases in order to become fully functional [20]. Molecules such as
PNAd (GlyCAM-1 and CD34) can interact with L-selectin and P-selectin to facilitate
4

tethering and rolling of naïve T cells and central memory T cells to lymph nodes.
Alternatively, PSGL-1 and CLA can interact with P-selectin and E-selectin respectively
to facilitate entry of memory and effector cells into inflamed organs [6] (Table 1.1).
Since selectin – selectin ligand interactions are temporally short, subsequent
steps must occur in order for cells to firmly attach to endothelial cells; a process that
requires the activation of integrins by chemokines.

Chemokines
Chemokines are small proteins that function to chemoattract cells by engaging
G-protein coupled receptors (GPCRs) [21,22]. The chemokine family consists of over
40 proteins that are organized into subfamilies based on the position of cystein residues
(CC, CXC, C, and CX3C) [21]. The initiation of chemotaxis depends on the coupling of
pertussis toxin sensitive Gαi proteins which orchestrate an inside-out signaling cascade
that results in a number of outcomes (lymphoid tissue organization, antigen
surveillance, and conformational changes to integrins) [23]. Once a leukocyte tethers
and rolls along endothelium, the cell is brought into close contact with chemokines that
are constitutively (homeostatic) or inducibly (inflammatory) expressed depending on the
condition of the site in which the cell is trying to access [24,25]. Under physiological
conditions, CCL21, CXCL13, and other chemokines are expressed on the surface of
endothelial cells of HEVs which can bind to cognate receptors (i.e. CCR7 and CXCR5),
located on naïve T cells, central memory T cells, B cells and other cell populations
[21,26]. However, during inflammation, effector subsets of T cells can express high
5

levels of other chemokine receptors (CCR4, CCR8, CCR9, and CCR10) in order to
access inflamed skin, lamina propriety or other sites via endothelial expression of
CXCL12, CCL25 and other chemokines [21,25,27].
Chemokines play important roles not only in recruitment of cells to extravascular
sites, but also in directing migration of leukocytes within those sites [21]. This is an
important mechanism because it facilitates the organization of cells in secondary
lymphoid organs in order to maintain homeostasis and initiate and direct adaptive
immune responses [21]. However, to enter the lymph nodes, chemokines on the
surface of high endothelial venues (i.e. CCL19) activate integrins so that firm adhesion
to endothelium can be achieved.

Integrins
Integrins have been shown to facilitate tethering and rolling along endothelium to
allow entry into organs in the absence of selectins. However, this process is not as
efficient as selectin mediated tethering [28,29]. The most notable function of an integrin
is its ability to firmly attach a mobile cell that is already rolling along the endothelium.
The process of firm attachment is rapidly triggered by chemokine receptor activation
such that the integrin can bind to a member of the immunoglobulin superfamily,
ICAM1,2,3 or VCAM1, expressed on the surface of the endothelium [30,31]. Integrins
are heterodimers consisting of an alpha chain and a beta chain and the integrins that
contribute to leukocyte arrest typically belong to the β2-integrin (i.e. LFA-1), α4 integrins
(i.e. VLA-4) and α4β7 subfamilies (i.e. LPAM-1) [25,32]. The diversity of alpha and beta
6

chains contributes to specificity in integrin-mediated arrest such that chemokine
triggered signaling might regulate distinct integrins and subsequent entry into specific
locations [25]. However, there is some evidence against the idea of selective
recruitment [33]. Nevertheless, this process of integrin activation could be due to
expression levels of chemokine receptors or possibly the chemokine receptors affinity
for a particular chemokine.
A migrating leukocyte typically expresses an inactivated integrin in a so called
“bent-low-affinity” conformation. Upon activation of the integrin, the bent conformation
changes to an “extended intermediate-affinity” or “high-affinity” conformation leading to
the opening of its ligand-binding pocket, firm adhesion and extravasation [23].

Sequential Adhesion Cascade
The ability for leukocytes to leave the blood and enter extravascular
compartments is dependent on the molecules that are expressed by the adherent
leukocyte and the endothelial cell. The first step mediated by selectin-selectin ligand
interactions facilitate the slowing down of the adherent cell through capture, tethering,
and rolling. Once the leukocyte begins to resist the stress of shear forces, chemokines
on the surface of the endothelium can provide stimulation to cognate chemokine
receptors to induce an inside-out signal responsible for opening the ligand-binding
pocket of specific integrins. The integrin can then interact with its respective cell
adhesion molecule to facilitate firm arrest, allowing the cell to crawl along the surface of
the endothelium and undergo extravasations. Each of these steps are required for
7

lymphocyte entry into secondary lymphoid organs (such as lymph nodes) and proper
delivery of lymphocytes to inflamed sites. The ability for lymphocytes to express
specific adhesion molecules along with specific chemokine receptors provide direction
to those cells that enable them to be delivered to the correct address in the body in
which they circulate.

T Cells

Hematopoietic stem cells in the bone marrow give rise to an array of progenitor
populations. Majority of these hematopoietic cells mature in the bone marrow, but T cell
development occurs in the thymus. The function of the thymus is to support a multistep
process to yield mature, self-tolerant, and functional T cells [34,35]. Progenitor T cells
produced in the bone marrow migrate towards the thymus via the blood and settle into
the thymus likely through rolling, adhesion, and extravasations; a process similar to
mature lymphocytes entering secondary lymphoid organs [36]. Once in the thymus,
immature non-T cell receptor (TCR) bearing CD4/CD8 double negative (DN) subsets
will undergo four developmental stages (DN1-DN4) based on the expression of CD44,
CD117, and CD25 [37]. In the DN1 stage, T cells are defined as CD44+ CD117+
CD25- that demonstrate the ability to proliferate and generate both αβ and γδ T cell
subsets [34]. Expression of CD25 on DN1 cells begins the DN2 (CD44+, CD117+,
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CD25+) stage, which is also characterized by extensive proliferation. Over time, CD44
and CD117 are downregulated, which begins the DN3 stage. During the DN3 stage,
the TCRβ, TCRγ, and TCRδ loci undergo recombination-activating gene (RAG) 1 and
RAG2 mediated rearrangement and are subsequently checked for successful
rearrangement [38]. Thymocytes containing a functional TCRβ chain can then
associate with a pre-TCRα chain and a CD3 molecule to form the pre-TCR complex
[34]. After the pre-TCR complex has been successfully checked and selected for αβ
lineage differentiation, cells will downregulate CD25 to enter the DN4 stage. While in
the DN4 stage, cells undergoing αβ lineage differentiation will expand and begin to
express CD4 and CD8 coreceptors (double positive – DP) and begin the rearrangement
of the TCRα locus. Conversely, γδ lineage differentiation is different from αβ
differentiation. During the DN3 to DN4 stage, development of γδ cells does not require
a pre-antigen receptor check; it only needs a single TCR-dependent event [39].
Once passing into the DP stage, RAG mediated TCRα chain rearrangement
stops and the DP (CD4 and CD8) cells can undergo positive and negative selection.
During positive selection, an intact three-dimensional microenvironment composed of
cortical epithelial cells, dendritic cells, and macrophages, which express MHC-I and
MHC-II is integral. DP thymocytes undergoing positive or negative selection will
interact with self-major histocompatibility complex (MHC) and if the TCR-MHC affinity is
strong the cell will likely undergo negative selection. It has been noted that TCR affinity
for positive selection ligands is lower than TCR affinity for negative selection [40].
Majority of thymocytes undergoing selection succumb to self-tolerance and are
9

eliminated via apoptosis (~95%) [35]. However, the DP thymocytes that do survive
positive selection will become single positive (SP) for CD4 or CD8. There are two
models that explain how this process occurs. In the instructive model of lineage
commitment, data suggests that whichever correceptor is engaged during the TCRMHC interaction will provide a specific signal which guides the cell towards that specific
lineage. Conversely, in the selective, or stochastic model, data suggests that CD4 or
CD8 expression is turned off randomly, driving the thymocyte towards a specific lineage
[41]. Once a thymocyte becomes CD4 or CD8 positive, sphingosine-1-phosphate
receptor-1 (S1P1) expressed on its surface will regulate T-cell egress from the thymus.
The S1P1 ligand, sphingosine-1-phosphate (S1P), is highly concentrated in the blood
and will diffuse into the thymus, causing the thymocytes to follow the S1P chemotactic
gradient [42]. Following the chemotactic gradient, thymocytes can exit the thymus and
enter into the blood circulation where they have the ability to populate secondary
lymphoid organs and recognize cognate antigen.

Characteristics of Naïve T cells
After successful development in the thymus, CD4 T cells will recognize antigen
presented by self-MHC-II molecules, while CD8 T cells will recognize antigen presented
by self-MHC-I molecules. This pool of mature cells, once in the blood, will begin to
circulate through secondary lymphoid and non-lymphoid organs and have the capacity
to display a strong reactivity to a wide spectrum of foreign antigens [43]. This capacity
to recognize and respond to an antigen presented by a self-MHC molecule is quite
10

amazing given the fact that there is an extremely low frequency of T cells that are
specific for any given antigen. However, T cells are able to overcome this obstacle
because of their ability to continuously migrate to different specialized locations. This
allows T cells to reach locations that give the T cells a greater opportunity to interact
with cognate antigen [9] (Figure 1.3).
The primary locations where T cells become activated are secondary lymphoid
organs [44]. The ability to enter into secondary lymphoid organs, such as lymph node,
is due to the expression of L-selectin (CD62L) and CCR7 on the surface of the T cell
along with the interactions of PNAd and CCL21 on the HEV [7]. Once in the lymph
node, CCL19 and CCL21 chemokines direct T cells towards a T cell area [21]. While in
the T cell area, naïve T cells have the capacity to interact with mature DCs that can
display antigen so that an effector response can be initiated if cognate antigen is
recognized [45].

Characteristics of Effector T cells
In the lymph node, if cognate antigen is recognized, naïve T cells become
activated and proliferate. Upon activation, T cells begin to highly express CD44,
downregulate L-selectin and CCR7, upregulate other adhesion-associated proteins
(fucosyltransferase –IV and –VII), and transiently express CD69 which leads to
transcriptional downregulation of S1P1 reducing the capacity for T cells to leave the LN
[43]. Due to the downregulation of S1P1, effector T cells will be retained and as such
accumulate in LNs where it is thought that the cells receive adequate programming
11

signals before exiting [46,47]. After about three days, effector T cells will become
responsive to S1P and exit the lymph node using S1P1. Once in the efferent
lymphatics, the T cells will enter the thoracic duct and subsequently end up in the blood
circulation where the effector T cell can migrate towards the target organ [48,49,50].
Once at the target organ, CD8 T cells can exert cytotoxic effects and eventually most
effector cells will die to give rise to a stable memory pool [51].

Two Classes of Memory T cells
Memory T cells have been classified as central memory (Tcm) or effector
memory (Tem) based on the expression of CD44, L-selectin, CCR7, and differences in
homing. Memory T cells that are CD44high, CD62Lhigh and CCR7+ have been classified
as central memory T cells, while those that are CD44high, CD62Llow and CCR7- are
classified as effector memory T cells [52]. When stimulated, effector memory T cells
exhibit effector cytokines more rapidly and proliferate faster than their central memory
counterparts [52]. Central memory T cells preferentially home to secondary lymphoid
organs while effector memory T cells are preferentially located in peripheral sites [5]
(Figure 1.4).

LCMV Response
Lymphocytic choriomeningitis virus (LCMV) is an arenavirus and a natural mouse
pathogen [53]. The virus, which has multiple strains (both acute and chronic), is a well-
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established viral model for studying CD8 T cell mediated responses [54]. During acute
LCMV (Armstrong strain) infection, a robust CD8 T cell response is elicited in spleen
and lymph node and is thought to be controlled primarily by CD8 T cells. However, CD4
and antibody specific B cells are also generated in the response [55,56]. In the case of
chronic LCMV infection (Clone 13 strain), the high antigen load causes clonal
exhaustion of CD8 T cells, leading to persistent infection [57]. In this thesis, we
exclusively use the acute infection of LCMV (Armstrong strain) in order to assess how
inflammatory conditions affect T cell trafficking.

T cell Trafficking
It is widely held that naïve T cells continuously circulate between secondary
lymphoid organs and the blood and that activated and memory T cells migrate through
non-lymphoid organs [7]. The data for this belief originated from an early study
performed in sheep where memory T cells were found in afferent lymph draining
towards the lymph node and naïve T cells were found in the efferent lymph draining
away from the lymph node [5]. Considering the fact that non-lymphoid organs do not
have HEVs and that naïve T cells primarily use HEVs to enter secondary lymphoid
organs, it led to the idea that these cells possessed no mechanisms by which to enter
non-lymphoid organs. Contrary to this, data has existed in the literature to suggest that
naïve T cells have the capacity to enter non-lymphoid organs [58,59]. In one study, it
was found that 30 minutes after intravenous injection of radiolabeled T cells into rats,
about half of the injected T cells entered secondary lymphoid organs while the other half
13

entered non-lymphoid organs [58]. The observation that naïve T cells can enter nonlymphoid organs suggests that there are numerous molecular adhesion mechanisms
that facilitate transmigration and that no one subset of cells is preferred. However, what
is clear is that certain adhesion molecules must undergo post-translational modifications
in order to become fully functional.

Glycosylation in Immunity

Covering the surface of nearly all mammalian cells are oligosaccharide-rich posttranslationally modified proteins that are attached to other membrane bound proteins
and lipids [20]. This layer of proteins is termed the glycocalyx and is a property of cells
that allows the cell to interact with its environment. The glycocalyx consists of
asparagine-linked glycans (N-linked), serine/threonine linked glycans (O-linked) and
lipid-linked glycans (glycolipids) [20]. The glycoconjugates represent linear and
branched polymers of a limited monosaccharide diversity linked through glycosidic
bonds [20]. However, despite the limited number of monosaccharides, the
combinatorial arrangement of the monosaccharides make these structures extremely
diverse. Assembly of the glycoconjugates occurs through the use of
glycosyltransferases, which are type II transmembrane proteins that contain their
catalytic domain in the lumen of the Golgi apparatus. Every glycosyltransferase is
classified according to the monosaccharide it requires and also by the way it constructs
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a glycosidic linkage (alpha-anomeric or beta-anomeric). The manner in which the
linkage is formed is indicated by numbers that denote which carbon atoms are involved
in the glycosidic bond between the monosaccharide and acceptor substrate [20]. Two
glycosyltransferases that have been implicated in the formation of selectin ligands are
fucosyltransferases–IV and –VII [60,61,62,63,64]. Fucosyltransferases –IV and –VII
catalyze the formation of an alpha anomeric glycosidic bond between carbon 1 on
fucose and carbon 3 of the acceptor substrate (GlcNAc) (Figure 1.2).

Fucosyltransferase-IV and Fucosyltransferase-VII
Considerable research has been conducted assessing the importance of
alpha1,3-fucosyltransferases –IV and –VII in immune cell trafficking (Table 1.3). In
1996, Lowe conducted a study looking at the phenotype of mice that lacked a targeted
disruption of the fucosyltransferase-VII gene [64]. They observed blood leukocytosis
and deficits in the expression of L-, E-, and P-selectin ligands as well as decreased
neutrophil, Th1, and Tc1 trafficking in inflammation using a contact hypersensitivity
model [20]. Subsequent experiments looking into the role of fucosyltransferase-IV have
shown that this enzyme plays an independent role in selectin-dependent recruitment of
leukocytes and that it contributes to HEV-derived L-selectin ligands, but that
fucosyltransferase-VII has a more prominant role [65]. Additional experiments looking
at the absence of both fucosyltransferases –IV and –VII has elucidated the importance
of these glycosyltransferases as lymphocyte homing to lymph node is severely reduced
in their absence [62]. The interesting feature of this significant defect is that despite the
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enzymes absence, CD4+ and CD8+ T cells are still able to mount a response to the
LCMV model of infection in visceral organs by becoming primed in the spleen [60]. This
data was further corroborated in the M. tuberculosis model of infection where the data
showed similar granuloma formation compared to WT [63]. These data suggested that
despite reduced total cellularity in the lymph nodes, a response could be initiated using
selectin ligand independent mechanisms. However, in the WT mouse
fucosyltransferase –IV and –VII are not the only enzymes that play a role in L-selectin–
selectin ligand-binding activity. An additional enzyme modification by a sulfotransferase
is required.

Sulfotransferases
Other integral glycosyltransferases in the formation of L-selectin ligands are the
GlcNAc-6-O-sulfotransferases [66]. The two enzymes in this group, Glcnac6st1 and
Glcnac6st2, function to add a sulfate group to the N-acetylglucosamine (GlcNAc) on Oglycans [67].

Rosen and colleagues found that the presence of a fucose residue in the

sialyl-LewisX moiety was not sufficient to mediate lymphocyte tethering and rolling using
L-selectin-selectin ligand interaction [68]. Since L-selectin is the primary selectin used
by naïve T lymphocytes and central memory T cells to tether and roll along high
endothelial venules at LNs, the proper modification of L-selectin ligands is critical for
proper trafficking into LN.
In order for increased L-selectin-selectin ligand interactions to occur, sulfation of
GlcNAc at the 6th carbon position to form 6-sulfo sialyl-LewisX needed to occur to
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enhance binding. Using knockout mice for different GlcNAc-6-O-sulfotransferases
(Glcnac6st1 -/-, Glcnac6st2 -/-, and Glcnac6st1-/- Glcnac6st2 -/- DKO) showed that the
absence of the enzymes contributed to a number of different phenotypes. Glcnac6st1-/Glcnac6st2 -/- DKO mice demonstrated an abolishment of rolling on HEVs [67,69].
However Glcnac6st1 -/- [70]and Glcnac6st2 -/- [71] single knockouts demonstrated an
overlapping function with Glcnac6st2 -/- mice revealing higher rolling velocities on HEVs
compared to Glcnac6st1 -/- mice. These experiments demonstrate that contribution to
selectin-selectin ligand specificity is complex and that there are a number of different
players that contribute to and are necessary for successful entry into lymph nodes.

Experimental Objectives

In the following studies presented in this thesis, we explore the role of
fucosyltransferases –IV and –VII in T cell trafficking. Specifically we test the following
hypotheses: 1) Naïve T cells accumulate in non-lymphoid organs when entry to LNs is
impaired; 2) FtDKO mice show changes in the lung environment, which allow selective
migration of T cells to that site; 3) Memory T cells use selectin ligand independent
mechanisms to enter lymph nodes; and 4) Memory T cells are selectively retained in
lymph nodes of FtDKO mice. We present evidence that support the hypotheses that
naïve T cells accumulate in non-lymphoid organs, like the lung, when entry to LN is
impaired and that memory T cells show increased homeostatic expansion and longer
residence in LNs with low T cell density.
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Figure 1.1. Mechanisms of T cell migration. Naïve T cell or central memory T cells
migrate across HEVs into lymph node using L-selectin, CCR7, and LFA1. Initial
tethering and rolling is mediated by selectin-selectin ligand interactions, followed by the
binding of chemokines to chemokine receptors, and then firm attachment via integrins.
Firm attachment will induce pseudopodia formation and subsequent extravasation into
organs.
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Figure 1.2. Depiction of selectin – selectin ligand interaction. A) L-selectin from an
adherent cell interacts with its HEV bound sialyl-LewisX ligand on PNAd. B) α1,3
fucosyltransferases catalyze the formation of an alpha anomeric glycosidic bond
between carbon 1 of fucose and carbon 3 of the GlcNAc acceptor. Additional sulfation
by GlcNAc-6-O-sulfotransferases forms the 6-suflo sialyl-LewisX moieties that are critical
for selectin ligand mediated tethering and rolling along the endothelium.
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Figure 1.3. Naïve T cell trafficking. T cell precursers migrate from the bone marrow
and develop in the thymus where they undergo negative and positive selection. Mature
T cells then leave the thymus and migrate through the blood and circulate through
secondary lymphoid organs as well as non-lymphoid organs. Naïve T cells will continue
to re-circulate until they come in contact with cognate antigen or die.
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Figure 1.4. Memory T cell trafficking. Central memory T cells express L-selectin and
CCR7 that allow them entry to LNs via HEVs. These cells primarily reside in secondary
lymphoid organs and rapidly proliferate following Ag exposure. Effector memory T cells
do not express L-selectin and primarily reside in non-lymphoid organs. Upon activation,
effector memory T cells rapidly elicit effector functions such as section of effector
cytokines (i.e. IFNg and Granzyme B).
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Table 1.1. Expression of Selectins and selectin ligands. (Adapted from von Andrian
and Mackay 2000)
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Table 1.2. Glycoprotein substrates that contain the Sialyl-LewisX structure. (Adapted
from von Andrian and Mackay 2000)
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Table 1.3. Glycosyltransferases relevant to selectin ligand biosynthesis. (Adapted from
Ley and Kansas 2004)
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Chapter 2
Naïve T cells re-distribute to the lungs of selectin
ligand deficient mice
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Research described in this chapter is a modified version of an article published in 2010
in PLoS One by John R. Harp and Thandi M. Onami
Harp J.R., T.M. Onami (2010) Naïve T cells redistribute to the lungs of selectin ligand
deficient mice. PLoS One 5: e10973
In this chapter, “our” and “we” refer to Thandi Onami and myself. My contribution to this
paper includes: 1) planning experiments, 2) analyzing data, 3) preparing figures, and 4)
editing.

Abstract
Selectin mediated tethering represents one of the earliest steps in T cell
extravasation into lymph nodes via high endothelial venules and is dependent on the
biosynthesis of sialyl Lewis X (sLex) ligands by several glycosyltransferases, including
two fucosyltransferases, fucosyltransferase-IV and –VII. Selectin mediated binding also
plays a key role in T cell entry to inflamed organs. To understand how loss of selectin
ligands (sLex) influences T cell migration to the lung, we examined fucosyltransferase-IV
and –VII double knockout (FtDKO) mice. We discovered that FtDKO mice showed
significant increases (~5-fold) in numbers of naïve T cells in non-inflamed lung
parenchyma with no evidence of induced bronchus-associated lymphoid tissue. In
contrast, activated T cells were reduced in inflamed lungs of FtDKO mice following viral
infection, consistent with the established role of selectin mediated T cell extravasation
into inflamed lung. Adoptive transfer of T cells into FtDKO mice revealed impaired T cell
entry to lymph nodes, but selective accumulation in non-lymphoid organs. Moreover,
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inhibition of T cell entry to the lymph nodes by blockade of L-selectin, or treatment of T
cells with pertussis toxin to inhibit chemokine dependent G-coupled receptor signaling,
also resulted in increased T cells in non-lymphoid organs. Conversely, inhibition of T
cell egress from lymph nodes using FTY720 agonisim of S1P1 impaired T cell migration
into non-lymphoid organs. Taken together, our results suggest that impaired T cell entry
into lymph nodes via high endothelial venules due to genetic deficiency of selectin
ligands results in the selective re-distribution and accumulation of T cells in nonlymphoid organs, and correlates with their increased frequency in the blood. Redistribution of T cells into organs could potentially play a role in the initiation of T cell
mediated organ diseases.

Introduction

Lymphocytes are highly migratory cells. Uncovering pathways that allow these
cells to access tissues not only facilitates our understanding of cell migration, but
deepens our understanding of the relationship between immunity and
immunopathology. Blood borne leukocytes, such as T lymphocytes, are recruited to
extra-vascular sites, and these processes are highly regulated so that distinct cell
populations are delivered to intended site(s) in the proper physiological or pathological
context (reviewed in[20,72,73]). Imperfections in these processes may lead to
qualitatively or quantitatively inappropriate delivery of cells to tissue sites that may result
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in inflammatory pathological processes (reviewed in [20]). Several leukocyte adhesion
deficiency (LAD) diseases in humans have been described, including LAD II, a
congenital immunodeficiency disease characterized by patients having defective
production of fucosylated ligands necessary for selectin mediated
tethering[74,75,76,77].
Selectins (E-selectin, P-selectin, and L-selectin) are type I transmembrane
glycan binding proteins (GBPs), or C-type lectins, that regulate leukocyte-endothelial
cell adhesive interactions, critically involved in T lymphocyte trafficking from the blood to
extra-vascular compartments [20]. Selectins interact selectively with sialylated
fucosylated lactosamine structures (sialyl Lewis x or sLex) of membrane-associated
mucin type glycoproteins such as GlyCAM-1, CD34, and MAdCAM-1 via binding by
amino terminal carbohydrate recognition domains (CRDs). The a1,3 fucosyltransferases
catalyze the synthesis of the sLex moiety, and thus these enzymes are essential in the
elaboration of selectin ligands, although additional modification by sulfotransferases
contributes to L-selectin binding [6,64,67,78]. Naïve and central memory T lymphocytes
express leukocyte selectin, or L-selectin, while activated T lymphocytes downregulate Lselectin, but begin to express E- and P- selectin ligands as a consequence of inducible
expression of a1,3 fucosyltransferases [79,80,81]. High endothelial cells which line
functionally distinct high endothelial venules (HEVs) in different lymph nodes,
constitutively express a1,3 fucosyltransferases, and this allows shear-dependent
adhesive interactions between lymphocytes and selectin ligands on HEVs [62,82].
Following initial selectin-mediated tethering of T cells, chemokine receptor binding of
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chemokines, such as CCR7 binding CCL21, activates G-coupled receptor signaling,
which induces a conformational change of T cell integrins, such as LFA-1 [83]. Binding
of high affinity LFA-1 on T cells leads to firm arrest and facilitates transendothelial
migration into the lymph node (LN) [83,84].
Mice lacking the a1,3 fucosyltransferases were generated several years ago and
demonstrate loss of selectin binding activity, impaired T cell migration to draining lymph
nodes but normal migration to spleen, as well as impaired T cell extravasation to skin in
both contact hypersensitivity and viral models [60,79]. However, knockout mice of one
or both enzymes are able to mount potent immune responses as evidenced by
clearance of lymphocytic choriomeningitis virus (LCMV), vesicular stomatitis virus
(VSV), and vaccinia viral infection in brain and ovaries, despite reduction of lymph node
T cell numbers [60,61,79]. Moreover, examination of fucosyltransferase-VII and-IV
double knockout mice (FtDKO) for immunity following infection with Mycobacterium
tuberculosis found that FtDKO mice had significantly diminished numbers of activated
CD8 and CD4 T cells in the draining lymph node of the lung (MedLN), but had effective
granuloma responses and similar recruitment of activated T cells into the lung at later
stages of infection [63]. Importantly, Mycobacterium tuberculosis infection of FtDKO
mice demonstrated that iBALT develops similarly in the lungs of FtDKO mice, and
express CXCL13, CCL21, and CCL19 chemokines [63]. This reduction in T cells in the
MedLN of FtDKO mice, even under conditions of chronic inflammation by an
intracellular pathogen, convincingly suggests that no major alternative mechanism of
cell recruitment compensates for the deficiency of a1,3 fucosyltransferases in T cell
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homing to the LN [63].
We were interested in determining how loss of selectin ligands affects immunity
at mucosal sites [85]. Here we report our discovery that FtDKO mice display a
significant increase in naïve T cell populations located in the lung. This phenotype has
never been reported in these mice, so we further explored the contribution of selectin
ligands to T cell migration into non-lymphoid organs. We examined T cell trafficking in
FtDKO mice under non-inflammatory conditions, as well as following inflammation due
to viral infection. The data presented here suggests that in FtDKO mice, T cells
selectively migrate and accumulate in non-lymphoid organs under non-inflammatory
conditions. However, under inflammatory conditions, T cell trafficking of Ag-specific
effector and memory T cell populations to non-lymphoid organs was reduced in FtDKO
mice, consistent with previous studies [86,87,88]. Finally, to investigate why naïve T
cells would preferentially accumulate in non-lymphoid organs of FtDKO mice under noninflammatory conditions, we considered two explanations: 1) a specific increase in
trafficking due to loss of selectin ligand expression in the lungs of FtDKO, making them
more permissive to T cell entry, or 2) a non-specific increase in trafficking to nonlymphoid organs due to T cell re-distribution when cells cannot enter LNs. We tested the
latter hypothesis and our results are consistent with this hypothesis. Treatments that
block T cell entry into the LN result in selectively increased numbers of T cells in nonlymphoid organs. Conversely, treatments that blocked T cell exit from the LN showed
reduced T cell trafficking to non-lymphoid organs. Thus, under conditions where T cell
entry to LNs is impaired, T cells may accumulate in the perivascular or interstitial
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campartments of the lung, and this altered distribution could possibly play a role in the
initiation of lung diseases.

Results

Increased numbers of naïve T cells in the lungs of FtDKO mice

We isolated lymphocytes from organs of naïve WT and FtDKO mice and
analyzed CD4 and CD8 T populations at each site. As expected, CD4 and CD8 T cell
populations were significantly reduced (~70%) in mediastinal lymph node (MedLN)
(Figure 2.1A, C). CD8 T cell populations were also reduced in the O-NALT. Surprisingly,
we observed ~5-fold increase in T cell numbers in the lungs of FtDKO mice, and we
also consistently observed a modest increase in T cell numbers in the spleen (~20%
increase) (Figure 2.1A, C). B cell populations were also increased in the lung, about 2fold (data not shown). Phenotypic analysis of T cell populations in organs of the FtDKO
mice reveal that similar to WT mice, the majority of T cells in the spleen and lung were
naïve (CD44lo and CD62Lhigh) (Figure 2.1B and data not shown). However, in the
MedLN and O-NALT of FtDKO mice, there was a significant decrease in naïve (CD44lo)
T cell populations (Figure 2.1B, D).
Since we saw increased numbers of T cells in the lungs of FtDKO mice, we
hypothesized that similar to CCR7-/- mice, FtDKO mice may show evidence of neo-
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lymphoid follicles or induced bronchus-associated lymphoid tissue (iBALT) in the lungs
[89]. However, H&E analysis of lung sections from FtDKO showed no evidence of
iBALT in any lung sections examined (Figure 2.1E). Analysis of T cells in lung sections
suggested increased T cells in the perivascular compartment, consistent with the
observed increase in T cell numbers by FACS analysis (Figure 2.1F). Taken together,
these observations raised the possibility that naïve T cells in FtDKO mice were redistributing to other organs, including non-lymphoid organs such as the lung.

Migration of Ag-specific CD8 T cells to inflamed lung is impaired in FtDKO mice

The role of selectin mediated recruitment of leukocytes to inflamed tissues is well
established [86,87,90]. Following inflammatory insult, E- and P-selectin are upregulated
on inflamed endothelial cells allowing for the recruitment of selectin ligand expressing
leukocytes. Naïve T cells express L-selectin, but not selectin ligands, while activated T
cells downregulate L-selectin, both transcriptionally and via proteolytic cleavage, and
induce expression of a1,3 fucosyltransferases, resulting in selectin ligand
expression[81,91,92,93].
We examined the expansion of Ag-specific effector and memory CD8 T cell
populations in the lungs of WT and FtDKO mice following LCMV Armstrong infection.
At day 8 and day 60 post-infection, we observed significant expansion of viral specific
CD8 T cells in organs of FtDKO mice (Figure 2.2A, B). However, CD8 T cell numbers
were significantly reduced (~50%) in the lungs of FtDKO mice compared to WT mice,
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consistent with the described role of selectin-mediated homing to inflamed lung (Figure
2.2C, D). Similar to a recent study, CD8 T cell numbers in the MedLN following infection
remained severely reduced (~85%) (Figure 2.2 C, D) [63]. Interestingly, we noted that
at day 60, Ag-specific memory CD8 T cells in MedLN and O-NALT were not reduced
(Figure 2.2B, D). In fact, FtDKO LN showed significant enrichment of Ag-specific
memory CD8 T cells compared to the total CD8 population (Figure 2.2 and J. R. Harp
and T. M. Onami manuscript in preparation).

Naïve and memory T cells preferentially accumulate in non-lymphoid organs in FtDKO
mice

Paradoxically, our results following infection show that effector and memory Agspecific CD8 T cell populations were reduced in the inflamed lungs of FtDKO mice,
while naïve CD8 populations were increased in the lungs of uninfected FtDKO mice
(Figures 2.1 and 2.2). Previously published studies have shown that defective T cell
migration to inflamed lungs was due to loss of expression of selectin ligands by T
cells—i.e. defective migration to inflamed tissues in FtDKO mice is T cell intrinsic [88].
However, defective T cell migration to LNs is due to loss of expression of selectin
ligands on HEVs [62,88]. In FtDKO mice, selectin ligand expression is absent in all
cells, including activated T cells.
To determine whether naïve or memory CD8 T cells, capable of expressing
selectin ligands, selectively homed to the lung of FtDKO mice, we performed adoptive
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transfer of bona fide P14.Tg WT naïve and central memory CD8 T cells into WT or
FtDKO recipient mice under non-inflammatory conditions. As expected, transferred T
cells were significantly impaired in homing to LNs as well as O-NALT in FtDKO mice
(Figure 2.3B). In contrast, we observed that transferred naïve and memory CD8 T cells
show increased numbers in the spleen, lung, and liver of FtDKO mice compared to WT
mice (Figure 2.3B, C). We saw no evidence of transferred T cells in the bronchial
alveolar lavage (BAL) (data not shown). The majority of transferred CD8 T cell
populations were located in the spleens of both WT and FtDKO mice (79% and 82%
respectively). The remaining CD8 T cells show differences in their distribution
comparing blood, liver, lung, cervical lymph node (CLN), iliac lymph node (ILN), and
MedLN (Figure 2.3C). In WT recipient mice, the majority of the remaining transferred
CD8 T cells preferentially homed to the LNs with a small fraction in non-lymphoid
organs (Figure 2.3C). In contrast, in FtDKO mice, the majority of the remaining
transferred CD8 T cells were preferentially located in the lung and liver, with few
entering the LNs (Figure 2.3C). Thus, consistent with our observation of increased
numbers of naïve T cells in non-lymphoid organs of FtDKO mice, these data
demonstrated that naïve and central memory CD8 T cells preferentially accumulated in
non-lymphoid organs in FtDKO mice.
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Inhibition of naïve T cell trafficking to LN by Pertussis toxin treatment results in selective
re-distribution to non-lymphoid organs

The observation of increased numbers of T cells in the lungs of FtDKO mice
could be due to several possibilities. One possibility is that loss of selectin ligand
expression in the FtDKO mice results in a change in the lung environment, making the
lung more permissive for T cell entry. A recent report observed that reduced sLex
expression on lung epithelial cells contributes to defects in airway wound repair [94].
Additionally, defects in core fucosylation have been associated with abnormal lung
development and an emphysema-like phenotype in Fut8 deficient mice [95,96]. Another
possibility is that by blocking T cell entry to the LN, T cells are re-distributed to other
sites. One place these naïve T cells end up is non-lymphoid organs, if these sites are
part of the normal migratory pathway of naïve T cells [9,12,97]. To test this hypothesis,
we examined whether inhibition of chemokine receptor signaling by pertussis toxin
treatment also results in increased migration of naïve CD8 T cells to lung and other nonlymphoid organs of recipient mice. In Figure 2.4, we show that as expected, Ptx
treatment of naïve CD8 T cells resulted in significantly impaired trafficking of transferred
cells to LNs, observed as decreased percentages and overall numbers of transferred
Thy1.1 cells in CLN, ILN, and MedLN (Figure 2.4B, C). In contrast, significantly more
naïve CD8 T cells were observed in the lung and liver (Figure 2.4C). We observed no
differences in numbers of transferred naïve CD8 T cells in spleen and bone marrow.
Notably, we observed an increased concentration of transferred Ptx treated T cells in
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the blood (Figure 2.4C). Additionally, if we treated recipient mice with blocking
antibodies to L-selectin (anti-CD62L), we also observed reductions in naïve CD8 T cells
in LNs, and increased T cells in lung and liver (Figure 2.6A and data not shown). Taken
together, these data support our hypothesis that general inhibition of T cell trafficking to
LN results in increased T cell re-distribution to non-lymphoid organs.

Retention of T cells in LN by FTY720 treatment results in reduced naïve CD8 T cell
populations in non-lymphoid organs

Thus far, our experiments demonstrated that when we inhibited entry of naïve
CD8 T cells via HEVs to LNs, we observed increases in the number of T cells in lung
and liver (Figure 2.3-2.4). Based on this result, we predicted that if we blocked T cell
egress from the LN, we would observe reduced T cells in the lung and liver. To test this
hypothesis, we transferred naïve CD8 T cells into recipient mice, and treated these mice
with FTY720, an agonist for S1P1, which inhibits T cell egress from the LN [98,99].
Treatment with FTY720 generally resulted in increased total lymphocytes in LNs and a
significant drop in total lymphocytes in the PBMC (Figure 2.5C). FACS analysis and
enumeration of the transferred naïve CD8 T cell population revealed that transferred
cells in treated mice were significantly lower in the liver, lung, and PBMC while
remaining unchanged in other organs (Figure 2.5D). Our study using bone fide naïve T
cells supports and extends data in a recent paper showing FTY720 treatment depletes
endogenous naïve phenotype T cells in peripheral organs [99].
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Relationship of naïve T cells in non-lymphoid organs and T cells in blood

If we focused our analysis on naïve CD8 T cells, a clear inverse relationship
emerges from our data (Figure 2.6). We used several methods to block T cell entry to
LN, including genetic ablation of selectin ligands (FtDKO mice), inhibition of G-coupled
dependent chemokine receptor signaling in T cells, or anti-CD62L treatment of mice to
inhibit CD62L dependent migration (Figure 2.6). In general, under conditions of
impaired migration to LN, we observed increased migration to non-lymphoid
compartments such as lung and liver (Figure 2.6A). In contrast, S1P1 agonism by
FTY720 treatment of mice results in retention of transferred naïve CD8 T cells in LN, but
resulted in a drop in naïve T cells in non-lymphoid organs (Figure 2.6A). Taken
together, the proportion of naïve T cells located in non-lymphoid organs was inversely
correlated with the proportion of naïve T cells in the LN (Figure 2.6A).
Under normal conditions naïve T cells emerge from the thymus and migrate via
the circulation into secondary lymphoid organs and exit LNs via the lymphatic vessels,
culminating at the thoracic duct, which drains into the superior vena cava, returning T
cells to the blood. We reasoned that treatments that inhibit naïve T cells in the blood
from entering the LN via HEVs, would result in higher proportions of naïve T cells
remaining in the blood. This higher proportion of T cells in the blood could result in
higher numbers of T cells that transit into the lung via the lung’s dual blood supplies, the
pulmonary and bronchial arteries, where T cells could accumulate in the lung
perivascular and interstitial compartments [12,100]. However, in the mouse it is
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generally agreed that there is limited blood supply from the bronchial arteries, so the
pulmonary arteries are the only blood supply to the lung, and T cells may enter lung
compartments after being sequestered in the pulmonary capillary bed [101,102,103].
Conversely, treatments that retain T cells in the LN, could reduce the proportion of T
cells in the blood, limiting the number of T cells that may potentially enter the lung.
We analyzed the proportion of transferred naïve CD8 T cells in the blood
following inhibition of LN entry, or inhibition of LN exit. For each treatment, we
calculated the ratio of the concentration of naïve T cells in the blood in treated versus
untreated groups of mice. We then considered whether this resulted in more T cells in
LN or non-lymphoid organs. Schematically, we show that there is an inverse
relationship between the concentration of naïve T cells in the blood and localization in
LN versus non-lymphoid organs (Figure 2.6B). Generally, when we inhibited naïve CD8
T cell entry to LN, via the HEVs using CD62L antibody blockade, genetic deficiency of
selectin ligands, or inhibition of chemokine receptor signaling via G-coupled receptor
signaling pathways, we observed more naïve CD8 T cells in the blood, and we also
observed more naïve CD8 T cells in non-lymphoid organs (Figure 2.6B). Conversely,
when we inhibited naïve CD8 T cell exit from the LN, via S1P1 agonism, fewer naïve
CD8 T cells were observed in the blood, and we observed fewer naïve CD8 T cells in
non-lymphoid organs (Figure 2.6B). Under homeostatic conditions, the majority of naïve
T cells preferentially home from the blood via HEVs into the LN, and we observe a
small, but measurable population of naïve T cells in non-lymphoid organs (Figure 2.1
and 2.6). Thus, our observation of increased naïve T cells in the lungs of FtDKO mice is
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consistent with our hypothesis that impaired T cell migration to secondary lymphoid
organs such as LN, results in increased T cells in the blood, and subsequently results in
migration and preferential accumulation in non-lymphoid organs.

Discussion

The focal event of the adaptive immune response is the encounter between
naïve T cells and APCs displaying specific antigen, which results in T cell activation.
Thus, our understanding of the immune system will be critically dependent on
characterizing the molecular events that regulate and guide highly migratory T cells and
APCs to appropriate microenvironments [104]. In this study, we have discovered a
previously unknown phenotype in FtDKO mice. We observed increased numbers of
naïve T cells in the lungs with no evidence of iBALT formation, and we demonstrated
that T cells selectively re-distribute to the lung, as well as several other organs in FtDKO
mice (Figure 2.1, 2.3). Viral infection of FtDKO mice to induce inflammation and trigger
viral-specific T cell expansion, demonstrated that while there was robust CD8 T cell
expansion and viral clearance by day 8, Ag-specific effector and memory CD8 T cell
populations were significantly reduced in the lungs of FtDKO mice, consistent with the
described role of selectin ligands in T cell extravasation to inflamed organs (Figure 2.2
and data not shown). Taken together, our data suggests that both selectin liganddependent and selectin ligand-independent mechanisms contribute to T cell migration to
non-lymphoid organs under inflammatory and non-inflammatory conditions,
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respectively.
To further understand the mechanism of T cell re-distribution and accumulation in
non-lymphoid organs under non-inflammatory conditions, we transferred bona fide
naïve and memory CD8 T cells and enumerated them in organs. However, it must be
considered that T cell migration is a very dynamic process and our analysis was limited
to one time point (18hrs post-transfer). Earlier or later times may have shown
differences in organ distribution of these transferred T cells. Nonetheless, our results
demonstrated preferential accumulation of both naïve and central memory T cell
populations in non-lymphoid organs of FtDKO mice (Figure 2.3). This observation is in
contrast to the main dogma that suggests these cells do not enter non-lymphoid organs,
but fits well with alternatively proposed migration models that suggest T cells
continuously enter lymphoid and non-lymphoid organs [24,33,105]. Moreover, we found
that conditions that inhibit T cell trafficking to the LN, and increase the proportion of T
cells in the blood, such as Ptx treatment and anti-CD62L blockade, also result in
increased naïve CD8 T cell trafficking to non-lymphoid organs (Figure 2.4 and 2.6). In
contrast, inhibition of T cell exit from the LN by FTY720 agonism of S1P1, which drops
the proportion of T cells in the blood, significantly reduced the number of naïve CD8 T
cells in lung and liver (Figure 2.5 and 2.6). Similarly, transfer of naïve CD4 T cells into
anti-CD62L treated recipient mice or FTY720 treated mice also showed alterations of
CD4 T cell numbers in the lung (S. Caucheteux and W.E. Paul, unpublished
observation). Taken together, these data suggest that when T cell trafficking to LN is
altered, this influences the concentration of T cells in the blood that enter the spleen and
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non-lymphoid organs such as the lung and liver. While this does not preclude the
possibility that additional changes in peripheral tissues of FtDKO mice may also
influence trafficking of T cells, it does suggest that altered T cell trafficking to LNs is
sufficient to cause increased T cell accumulation in several organs.
Normal re-circulation of T cells to secondary lymphoid organs such as LN,
spleen, and mucosa associated lymphoid tissues such as O-NALT, is thought to be
important for T cell interaction with stromal cells expressing IL-7 and other survival
cytokines [106,107]. As noted above, there is controversy in the literature regarding
whether naïve T cells normally migrate into non-lymphoid organs. Several reviews and
textbook discussions report that only effector and memory T cells enter non-lymphoid
organs, and naïve T cells do not normally enter these sites [5,6,24]. However, other
studies have reported that as part of the normal migratory pathway, naïve T cells enter
non-lymphoid organs including lung, but naïve T cell residency time in these organs is
short compared to effector/memory T cells [9,12,13,33,59,97]. Recently published data
has shown that lung and liver are also sites of significant IL-7 production as measured
by RNA message level [108]. Possibly, naïve T cells that migrate into highly
vascularized organs such as liver and lung, are able to receive sufficient IL-7 survival
signals that sustain them in these microenvironments. Moreover, several recent papers
have shown that T cells are capable of responding to viral antigens in organs and T
cells are not dependent on trafficking to draining lymph node for priming [109,110,111].
Neo-lymphoid aggregates or follicles have been described in both liver and lung, and
are proposed to be sites of potent T cell immune responses [110,111].
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The importance of elucidating mechanisms by which T cells, as well as other
inflammatory cells, migrate into and out of the lung is underscored by the global health
burden associated with lung diseases including COPD, asthma, and lung metastasis.
Our data examining uninfected FtDKO mice revealed substantial increases in naïve T
cells in the lung, and uncovered a selectin-ligand independent pathway of T cell
migration in the absence of lung inflammation. Several years ago, another group
published a study describing selectin-independent mechanisms of trafficking to the
inflamed lung following Mycobacterium tuberculosis infection of FtDKO mice [63].
Similar to our data, they showed that activated CD8 T cell numbers were reduced in the
lung early and late following infection, but these mice were able to control the infection
comparable to WT mice [63]. However, the study’s authors concluded that recruitment
of effector T cells to lungs was solely selectin-independent, and argued that the
decreased numbers they observed following infection was due to a delay in priming of T
cells. Since LCMV efficiently primes T cells in the spleen, where we observed no
defects in T cell migration, we conclude that our observation of decreased Ag-specific
CD8 T cells in lung was likely due to the contribution of selectin-ligands in T cell homing
to inflamed lung consistent with earlier work [86,88,90]. However, our study is
consistent with Schreiber et. al.’s conclusion that substantial numbers of activated CD8
T cells are able to migrate into the lung and peripheral organs in a selectin ligandindependent manner [60,63].
Selectin mediated binding initiates the earliest step of lymphocyte extravasation
by slowing lymphocyte rolling along HEVs. As demonstrated, the loss of selectin ligand
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expression results in profound impairment in T cell extravasation to LN [62]. However,
for T cell entry to the lung parenchyma, it is possible that physical slowing in the small
capillaries of the lung is sufficient for T cells to efficiently enter lung routinely as part of
normal migration [9,12,13]. Several studies have documented that the normal diameter
of a capillary in the lung is ~7mm which requires that larger leukocytes, such as
lymphocytes and granulocytes, undergo cytoskelatal rearrangment for cell deformation
and elongation in order to pass through pulmonary capillary beds. Otherwise, these
cells become sequestered at these sites [101,112,113]. If so, when the proportion of
lymphocytes in the blood increases, such as under inflammatory conditions, or when T
cell entry to the LN is blocked, T cell entry to the lung may increase as T cells become
trapped in the capillary bed, and move into adjacent perivascular and intersitial
compartments of the lung. Thus, selectin-mediated binding likely enhances an already
effective entry process to the inflamed lung. Furthermore, additional cell adhesion
molecules expressed by effector and effector memory T cells also enhance trafficking,
as well as retention, in peripheral organs such as lung [114,115]. The presence of
antigen and/or changes in chemokine expression in tissues following microbial infection
will also influence naïve T cell migration/retention in non-lymphoid organs [116].
In summary, our data discovered that FtDKO mice had a significant increase in
naïve T cells in the lungs, and demonstrated increased naïve and central memory T cell
accumulation in non-lymphoid organs. Furthermore, we observe an inverse relationship
between naïve T cell location in LN and non-lymphoid organs. By inhibiting T cell entry
to or exit from the LN, we show that the ratio of naïve T cells in the blood is altered, and
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this influences the number of naïve T cells that re-distribute to non-lymphoid organs. In
patients with leukocyte adhesion deficiency diseases, where patients suffer from
recurrent infections, including a significant proportion of respiratory infections, altered
leukocyte trafficking may influence disease development in certain organs
[117,118,119]. Proposed immunosuppressive therapies that target or alter trafficking of
T cells into or out of the LN should consider that such treatments will likely influence the
distribution of T cells in blood, and consequently, increase T cell accumulation in nonlymphoid organs, including the lung [120,121].

Materials and Methods

Mice and Immunizations

Fucosyltransferase -IV and -VII double knockout (FtDKO) mice, backcrossed at least 9
generations to C57BL/6 were originally generated by Dr. John Lowe [62]. Mice were
obtained from the Consortium for Functional Glycomics (Scripps Research Institute, La
Jolla, CA) and bred in-house as homozygous double knockouts, but breed poorly.
Transgenic P14xThy1.1 mice were provided by Dr. Rafi Ahmed (Emory Vaccine Center,
Atlanta, GA) and bred in-house. C57BL/6 (WT) mice were purchased from The
Jackson Laboratory. Memory P14xThy1.1 chimeric mice were generated by adoptive
transfer of 5x105 total splenocytes from transgenic P14xThy1.1 mice into C57BL/6
recipients and infected with 2x105 pfu LCMV-Armstrong. FtDKO and C57BL/6 wildtype
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control mice were immunized intraperitoneally (i.p) with 2x105 pfu LCMV-Armstrong. All
mice were maintained under specific pathogen-free conditions at the University of
Tennessee in accordance with IACUC guidelines and used at age 2 to 6 months. All
animals were handled in strict accordance with good animal practice as defined by
University of Tennessee IACUC committee and all animal work was approved by the
committee.

Naïve and Memory Cell Trafficking

Where indicated, MACS (Miltenyi Biotech, Auburn, CA) purified naïve and memory
P14xThy1.1 CD8 T cells (2x106) from the spleen were adoptively transferred into WT or
FtDKO recipient mice. Naïve cells were labeled with carboxyfluorescein succinimidyl
ester (CFSE) in order to differentiate transferred naïve and memory P14xThy1.1 CD8 T
cell populations. Equal numbers of Ag-specific CD8 T cells were injected intravenously
(i.v.) via tail vein. In pertussis toxin (Ptx) inhibition experiments, P14xThy1.1
splenocytes were pretreated with Ptx (Calbiochem, Gibbstown NJ) or PBS for 90
minutes at 37°C [59] and 1x106 Ptx or PBS treated Ag-specific CD8 T cells were
adoptively transferred into WT recipient mice. For anti-CD62L experiments, 100µg of
MEL-14 (α-CD62L) blocking antibody (BioXcell, W. Lebanon, NH) was injected i.v. into
WT recipient mice. Four (4) hours post treatment, 1x106 P14xThy1.1 CD8 T cells were
injected i.v. into mice. In FTY720 experiments, 1x106 P14xThy1.1 CD8 T cells were
adoptively transferred into recipient WT mice, followed by treatment with 1mg/kg
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FTY720 (Calbiochem) or water i.p. with treatment every 24hrs for 3 days total.

Organ Harvest, Flow Cytometry, and Histology

At indicated time points mice were sacrificed, organs were perfused with 5ml cold PBS,
and tissues harvested for processing as previously described [85,122]. Briefly, perfused
organs were minced, incubated with HBSS+ 1.3mM EDTA solution for 30 minutes at
37oC, re-suspended in 225U/ml type I collagenase for 60 minutes at 37oC, and cells
were centrifuged using a Percoll density gradient to isolate lymphocytes from the
parenchyma. Single cell suspensions were stained with DbNP396-404 or DbGP33-41
tetramers, provided by the NIH Tetramer Facility (Atlanta, GA), and mAbs (CD8, CD4,
CD44, CD62L, Thy1.1, Thy1.2) [54]. Total number of cells in bone marrow was
calculated by multiplying the number of cells from two femurs x 7.9 [123,124]. Numbers
of cells in PBMC are shown as per 106 cells. Monoclonal antibodies were purchased
from BD (La Jolla, CA). All samples were run on a FACSCalibur (BD Biosciences) and
analyzed with FlowJo software (Treestar). For histology, lungs were infused with 1mL of
50% OCT (Tissue Tek, Torrance, CA) in PBS, embedded in OCT, and frozen on dry ice,
and stored at –80oC. Serial sections were cut at 7 µm and stained with hematoxylin and
eosin using routine staining procedures. Lung sections were also stained with
biotinylated primary Ab, Thy1.2 (1:1500; BD Biosciences), followed by Alexa Fluor 568
conjugated streptavidin (1:400; Invitrogen, Eugene, OR), and analyzed using an
epifluorescent microscope (Nikon Eclipse E600). For transfer studies, to calculate the
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proportions of transferred cells in different organs, total Thy1.1+ CD8+ T cells in
indicated organs were enumerated. The number of transferred cells in each tissue was
then divided by the total Thy1.1+ CD8+ cells in examined organs. Statistical significance
was determined using unpaired student t tests where *indicates p<0.05, ** p<0.01, and
*** p<0.001.
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Appendix
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Figure 2.1. Increased numbers of naïve T cells in lungs of FtDKO mice. Lymphocytes
were isolated from WT and FtDKO mice. A and B, Representative FACS analysis of
organs from WT or FtDKO mice. Cells were stained with CD4, CD8 and CD44 mAbs.
Numbers indicate percent of CD4, CD8, or CD44Lo CD8 T cells. C, Enumeration of CD8
and CD4 T cells in indicated organs. D, Enumeration of CD44 Lo CD8 or CD44 Lo CD4 T
cells in indicated organs. E, Photomicrographs of representative H & E staining of WT
and FtDKO lungs at x40 magnification. F. Photomicrographs of representative immuno
histology staining of T cells using Thy1 of WT and FtDKO lungs at x200 magnification.
Data was collected from n=6 WT and n=7 FtDKO in two independent experiments. For
O-NALT, one experiment is shown where cells were pooled from n=4 mice/group. The
unpaired Student t test was used to compare groups. (*p<0.05, ** p<0.01, and ***
p<0.001)
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Figure 2.2. Ag-specific CD8 T cells are reduced in inflamed lung of FtDKO mice. WT
or FtDKO mice were infected with LCMV-Armstrong i.p and lymphocytes were isolated
on day 8 or day 60 p.i. A, Representative FACS analysis of single cell suspensions
from indicated organs on day 8 p.i. Cells were stained with CD8, CD44 and DbNP396404 tetramer. Gating on CD8 T cells, numbers in FACS panels indicate percent of Agspecific CD8 T cells in organs. B, Representative FACS analysis of single cell
suspensions from indicated organs on day 60 p.i. Cells were stained with CD8, CD44
and DbGP33-41 tetramer. C, Enumeration of Ag-specific, CD44high, and total CD8 T
cells in WT or FtDKO mice at day 8. D, Enumeration of Ag-specific, CD44high, and total
CD8 T cells in WT or FtDKO mice at day 60. For day 8, n=2 WT and n=3 FtDKO. For
day 60, n=4 WT and n=4 FtDKO. For O-NALT, organs were pooled from each group.
(*p<0.05, ** p<0.01, and *** p<0.001)
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Figure 2.3. T cells preferentially accumulate in non-lymphoid organs of FtDKO mice.
CD8 T cells were purified from naïve Thy1.1xP14 Tg mice (CFSE+) or immune (day 200
p.i.) Thy1.1xP14 Tg chimeric mice (CFSE-), transferred into WT or FtDKO recipient
mice, and recipient mice were sacrificed 18 hours later. Thy1.1 was used to differentiate
endogenous from transferred T cell populations from indicated organs. A, Experimental
design and phenotype of transferred cell populations. B, Enumeration of transferred
CD8 T cell populations in indicated organs. C, Pie charts showing the distribution of
Thy1.1 cells in WT and FtDKO recipient mice in spleen, PBMC, liver, lung, CLN, ILN,
and MedLN. Of the indicated organs, ~80% of transferred cells are located in spleen.
The smaller pie chart shows the distribution of the remaining transferred cells. Data
was collected from n=5 WT and n=6 FtDKO from two independent experiments.
(*p<0.05, ** p<0.01, and *** p<0.001)
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Figure 2.4. Inhibition of T cell trafficking to LN by pertussis toxin treatment results in
selective re-distribution of naïve T cells to non-lymphoid organs. Splenocytes from
Thy1.1xP14 Tg mice were treated with either pertussis toxin (Ptx) or PBS control and
transferred into WT recipient mice. 18 hours post transfer, T cells were isolated from
indicated organs and analyzed by FACS. A, Experimental design. B, Representative
FACS analysis of indicated organs gating on CD8 T cells. Numbers indicate percentage
of transferred cells in the indicated organ. FACS staining from animals that received
untreated cells, Ptx-treated cells, or received no transferred cells are shown. C,
Enumeration of transferred cells in organs. Data was analyzed from n=3 control
untreated and n=4 Ptx treated groups. (*p<0.05, ** p<0.01, and *** p<0.001)
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Figure 2.5. Retention of naïve T cells in LN by FTY720 treatment depletes naïve T cell
populations in non-lymphoid organs. Splenocytes from naïve Thy1.1xP14 Tg mice were
adoptively transferred into WT recipient. Recipient mice were treated for three days
with FTY720 and lymphocytes in organs analyzed by FACS. A,Experimental design. B,
Representative FACS analysis of indicated organs. Gating on CD8 T cells, numbers
indicate percentage of transferred cells. C, Total lymphocyte numbers isolated from
indicated organs. D, Transferred Thy1.1+ CD8+ T cells from indicated organs. Data
from one representative experiment is shown, with n=2 control and n=3 FTY720 treated
mice. (*p<0.05, ** p<0.01, and *** p<0.001)
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Figure 2.6. Naïve T cell migration to non-lymphoid organs is influenced by T cell
concentration in the blood. Proportions of transferred naïve T cells in selectin ligand
deficient mice (FtDKO), Gαi signal disruption (Ptx), CD62L blockade, and FTY720
treated mice are shown. A, Total number of transferred naïve CD8 T cells in CLN,
MedLN, ILN, liver, and lung was calculated, and the percent of transferred naïve CD8 T
cells in LNs versus non-lymphoid organs is shown for each treatment group. B, The
relationship of naïve CD8 T cells in the blood compared to naïve CD8 T cells in organs
(LN versus non-lymphoid organs). Concentration of naïve CD8 T cells in PBMCs was
determined for each animal and the ratio of treatment versus control for each treatment
group is shown (R=1 for control, untreated group). Data is shown from 5 independent
experiments for a total of n=28 mice.
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Chapter 3
Memory T cells are enriched in lymph nodes of
selectin ligand deficient mice

60

Research described in this chapter is a modified version of a submitted manuscript by
John R. Harp, Michael A. Gilchrist, and Thandi M. Onami
Harp J. R., M. A. Gilchrist, T. M. Onami (2010) Memory CD8 T cells are enriched in
lymph nodes of selectin ligand deficient mice. J. Immunol. Submitted
In this chapter, “our” and “we” refer to the co-authors and myself. My contribution to this
paper includes: 1) planning experiments, 2) analyzing data, 3) preparing figures, and 4)
editing.

Abstract

Mice deficient in expression of fucosyltransferases –IV and –VII (FtDKO) reveal
profound impairment in T cell trafficking to LNs due to an inability to synthesize selectin
ligands (sialyl Lewis X, sLex). We observed an increase in the proportion of
“memory/effector” (CD44high) T cells in LNs of FtDKO mice. We infected FtDKO mice
with LCMV to generate and track Ag-specific CD44high CD8 T cells in secondary
lymphoid organs (SLO). Although frequencies were similar, total Ag-specific effector
CD44high CD8 T cells were significantly reduced in LNs, but not blood, of FtDKO mice at
day 8. In contrast, frequencies of Ag-specific memory CD44high CD8 T cells were up to
8-fold higher in LNs of FtDKO mice at day 60. Since WT mice treated with anti-CD62L
treatment also showed increased frequencies of CD44high T cells in LNs, we
hypothesized that memory T cells were preferentially retained in, or preferentially
migrated to, FtDKO LNs. We analyzed T cell entry and egress in LNs using adoptive
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transfer of bone fide naïve or memory T cells. Memory T cells were not retained longer
in LNs compared to naïve T cells, however, T cell exit slowed significantly as T cell
numbers declined. Memory T cells were profoundly impaired in entering LNs of FtDKO
mice, however, memory T cells exhibited greater homeostatic proliferation in FtDKO
mice. Taken together, we conclude that FtDKO LNs are enriched in memory T cells due
to longer retention because of low T cell density, and increased homeostatic expansion.

Introduction
As part of immune surveillance, T cells continuously re-circulate through
lymphoid and non-lymphoid organs via the blood and lymph. The vast majority of T cells
enter lymph nodes from the blood via high endothelial venules (HEVs), while a smaller
fraction enters LNs through the afferent lymphatics, which drain the interstitial fluids of
organs and mucosal associated lymphoid tissues (MALT). In general, it is thought that
naïve T cell populations preferentially home to lymphoid organs, while memory T cells
preferentially home to either bone marrow and lymphoid organs (T central memory), or
non-lymphoid organs (T effector memory) [24,114,125]. However, several groups have
also observed that naïve T cells regularly circulate through non-lymphoid organs such
as lung, and alternative models have been proposed to account for these observations
[9,33,59,105].
Selectin mediated tethering represents the earliest step in T cell entry to the LN
via the HEVs. For naïve and central memory T cells this step is mediated through the
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interaction of L-selectin expressed on the T cell, with selectin-ligands expressed on
HEVs. L-selectin ligands are sialylated, fucosylated, and sulfated structures whose
synthesis depends on the activity of several glycosyltransferases including a1,3
fucosyltransferases which are absolutely required for the synthesis of sialyl Lewis X
(sLex) [20,73]. Mice deficient in both fucosyltransferase -IV and -VIII (FtDKO) are
profoundly deficient in T cell trafficking to the LN due to loss of expression of sLex by
HEVs [62,64]. Additionally, L-selectin ligands are further modified by the activity of two
sulfotransferases, and addition of these sulfated sLeX structures to glycoproteins such
as PNAd, GlyCAM and MadCAM, allow naïve and central memory T cells to tether on
HEVs, initiate chemokine dependent signaling through CCR7, and initiate firm arrest
and transendothelial migration via activated integrin receptors such as LFA-1 [24,67,84].
In contrast to naïve T cells, activated T cells down-regulate L-selectin but induce
expression of fucosyltransferases -IV or -VII and begin to express selectin ligands on
modified T cell glycoproteins such as PSGL-1 [79,81,126]. As a consequence, activated
T cells are able to interact with E- and P-selectin expressed on inflamed endothelial
cells to initiate tethering and slow rolling under shear forces. Additionally, activated T
cells increase expression of the adhesive proteoglycan CD44 and several integrins
including VLA-4 that also contribute to slow rolling [127,128]. Moreover, studies have
shown that effector/memory T cells are enriched in the afferent lymph and peripheral
organs, allowing these T cells to bypass the requirement for selectin mediated
trafficking by entering LNs via the afferent lymph [98,129].
Recently, we discovered that naïve T cells preferentially re-distributed and
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accumulated in non-lymphoid organs such as the lung in FtDKO mice [130]. In the
present study we have further examined FtDKO mice to understand how alterations in T
cell trafficking to LNs affect memory T cell localization and homeostasis. Here we
present our observations that FtDKO mice show a significant increase in the frequency
of memory T cells in LNs, although total T cell numbers are reduced in LNs. Antibody
treatment of WT mice using anti-CD62L (L-selectin) recapitulated the increase in the
ratio of memory T cells in LNs. We tested whether Ag-specific CD44high effector or
memory CD8 T cells showed alterations in trafficking to FtDKO LNs following LCMV
infection. Our results demonstrated that Ag-specific memory, but not effector T cells,
were significantly enriched in the LNs of FtDKO mice, even though memory T cells
remain severely impaired in homing to LNs of FtDKO mice. Further, although
substantial numbers of memory T cells homed to the bone marrow and spleen in both
WT and FtDKO mice, T cells transferred into FtDKO mice show significantly increased
homeostatic proliferation. We suggest that longer residency times of memory T cells in
LNs with few lymphocytes, and increased homeostatic expansion together contribute to
the preferential accumulation of Ag-specific memory T cell populations in LNs of FtDKO
mice
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Results

Increased frequency of CD44high T cells in LNs of FtDKO mice

We isolated lymphocytes from organs of age-matched naïve WT and FtDKO
mice. As has been shown previously, total cell numbers in the LNs of FtDKO mice was
significantly reduced [62]. We observed a significant decrease in CD8 T cell numbers in
the LN of FtDKO mice, with concomitant increases in spleen and blood (Figure 3.1B).
However, analysis of the activation/memory marker CD44 on T cell populations
revealed that while frequencies of CD44high T cells were similar in most organs, in the
LNs and mucosal associated lymphoid tissues, the frequency of CD44high T cells was
significantly higher in FtDKO mice (Figure 3.1A and C). Analysis of the number of
CD44high CD8 T cells in organs revealed that while these effector/memory CD8 T cells
were generally reduced in the LN of FtDKO mice, the impairment was not as great as
the reduction in total T cells. These data suggested that the impairment of trafficking of
T cells to some secondary lymphoid organs (SLOs) in the absence of selectin ligands
may not be as severe for effector/memory T cell populations.

Similar frequency of day 8 Ag-specific effector CD44high CD8 T cells, but reduced
number in LNs of FtDKO mice

We then investigated expansion and trafficking of CD44high Ag-specific effector
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CD8 T in lymph nodes following viral infection. WT and FtDKO mice were infected with
2x105 pfu of LCMV Armstrong i.p. and Ag-specific CD8 T cells were enumerated in
blood and SLOs (Figure 3.2). As expected, CD8 T cells in WT and FtDKO mice similarly
down-regulate expression of CD62L by day 8 post-infection, although expression levels
of CD62L were slightly elevated on naïve T cells in FtDKO mice (Figure 3.2A). Both WT
and FtDKO mice show similarly high frequencies of Ag-specific CD44high CD8 T cells
and total CD44high CD8 T cells in PBMCs and LNs on day 8 p.i. (Figure 3.2B, D, E).
However, we observed a significant reduction in total CD8 T cell numbers in LNs of
FtDKO mice compared to WT mice, and as a consequence we also observed
significantly reduced Ag-specific CD8 T cells in the LNs (Figure 3.2C). Thus, while the
frequencies of effector CD8 T cell populations were comparable between WT and
FtDKO mice, expression of selectin-ligands remains critically important in achieving
normal numbers of Ag-specific CD44high effector CD8 T cells in the LNs following viral
infection. These data extend the findings of two previous studies using contact
hypersensitivity (CHS) challenge of skin or intranasal Mycobacterial infection of FtDKO
mice, showing loss of selectin ligands significantly impairs activated T cell migration to
LNs [63,64].

Ag-specific memory CD44high CD8 T cells are abundant in LNs of FtDKO mice

We concluded from our analysis of effector CD44high CD8 T cells in LN that
despite studies suggesting cooperative interaction of CD44 and VLA-4 to enable slow
66

rolling of activated T cell populations, T cells require expression of fucosyltransferases
and synthesis of selectin ligands for activated T cell entry to the LN, as described in
earlier studies [79,81,128]. In contrast to our findings with Ag-specific effector CD8 T
cells at day 8, our analysis of Ag-specific memory CD8 T cell populations in LNs of
immune FtDKO mice revealed significant increases in the frequencies of memory cells
compared to WT mice at day 60, (Figure 3.3A, C). Similar to our observations in
uninfected FtDKO mice, in day 60 immune mice, the frequency of CD44high CD8 T cell
populations was increased in LNs of FtDKO mice (Figure 3.3E). Importantly, despite our
continued observation that total CD8 T cells remained substantially reduced in LNs of
FtDKO mice, the significantly higher frequency of Ag-specific memory CD8 T cells in the
LNs resulted in comparable numbers of Ag-specific memory CD8 T cells in LNs of WT
and FtDKO mice (Figure 3.3B and D). Thus, despite the loss of selectin ligands, Agspecific memory T cells were similarly abundant in the LNs of FtDKO mice.
There were several possible explanations for our results demonstrating
increased frequencies of memory T cells in the LNs of FtDKO mice. T cell density has
been associated with T cell survival, and it was possible that there was increased
survival of memory T cells in LNs of FtDKO mice. However, studies that have examined
T cell survival and density have found that high T cell density favors survival, while low
T cell density results in increased apoptosis [131]. Therefore, we initially considered two
explanations to test experimentally. One possible explanation was that in contrast to
naïve or effector CD8 T cell populations, Ag-specific memory CD8 T cells were being
preferentially retained in LNs of FtDKO mice. A second hypothesis was that memory T
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cells were preferentially homing to the LNs of FtDKO mice via selectin ligand
independent mechanisms.

Ratio of Memory T cells increases in WT mice following inhibition of L-selectin mediated
entry

To test whether inhibition of T cell entry changed the ratio of naïve versus
memory T cell populations, we treated normal mice with anti-CD62L. As expected,
treatment of WT mice with anti-CD62L resulted in a significant reduction in total CD8 T
cell numbers in the LNs, but not spleen (Figure 3.4A). However, this reduction in total
CD8 T cell numbers was almost entirely due to a decrease in naïve CD44low CD8 T cells
(Figure 3.4A). In contrast, the memory/effector CD44high population was relatively
stable, and we observed a significant increase in the percentage of CD44high CD8 T
cells in LNs, similar to our observations in FtDKO mice (Figure 3.4A, B). Similar results
were observed with the CD4 T cell population (data not shown). Thus blockade of T cell
entry via the L-selectin mediated HEV-dependent pathway results in the increased
frequency of endogenous effector/memory CD44high T cell populations in LNs similar to
the observed increases in FtDKO mice (Figure 3.1). This observation was consistent
with data presented in an elegant recent study which suggested that memory T cells
were retained for longer periods in LNs [132]. However, in both studies, T cells were
activated by an unknown, endogenous antigen, and we cannot determine what
proportion of the CD44high memory/effector population was proliferating in response to
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endogenous antigen present in the LN. Thus, whether memory T cells in the absence of
specific antigen show differences in retention in LN was unclear.

Exit rates of naïve and memory CD8 T cells from LN are similar, but residency time in
the LN is density-dependent

To directly test the hypothesis that memory T cells were retained longer in the
LNs compared to naïve T cells, we transferred bone fide Thy1.1+ naïve or memory CD8
T cells with the same TCR specificity into WT Thy1.2+ recipient mice. We used the P14
transgenic TCR specific for the GP33-41 peptide of LCMV. Both populations of Thy1.1+
CD8 T cells were CD62Lhigh and either CD44low (naïve, antigen-inexperienced), or
CD44high (memory, antigen-experienced). Following transfer into recipient mice, further
T cell entry was blocked with anti-CD62L treatment of mice to measure the decay in
transferred T cell populations in different organs over time. We then calculated the exit
rate of these T cell populations. This evaluation allowed us to determine whether
memory T cells show differences in residency time in LNs compared to naïve T cells.
There was one zero cell count for both the memory and naive cell populations.
Both zeros occurred in the MedLN at 48 hours but in separate mice. Because we were
working with log-transformed data, these zero counts were replaced with the lowest
non-zero count for the entire dataset (13.2 cells). The best fit model was the one which
assumed that egress rates differed between the early, 0 to 8 hours, and the late, 24 to
48 hours, time periods (F = 21.035, df = 1, p-value < 10-4), but where the exit rate was
69

the same for both memory and naive cell types within each time frame (F = 0.0682, df =
2, p-value >0.9) for all LNs except for the late ILN treatment (F = 9.1651, df = 1, p-value
<0.005). The egress parameter estimates are summarized in Table 3.I.
Our analysis revealed that naïve and memory CD8 T cells showed no statistical
differences in exit rates from the LNs (Figure 3.5). Initially, both naïve and memory CD8
T cell populations show residency times of about 5-6 hrs in LNs, with memory T cells
showing a slight trend towards faster exit. However, our data also revealed that as the
density of lymphocyte populations decreased in the LN over the treatment time (due to
anti-CD62L blockade of new lymphocyte entry to LNs with continued cell exit), the rate
of T cell egress significantly slowed for both naïve and memory T cell populations to
about 15-16 hrs in some LNs, to as much as 84 hrs (3.5 days) in others (Table 3.I).
Several studies examining T cell recirculation have suggested that T cell migration
through the T cell area of the LN is slowed when T cell density is reduced, resulting in
reduced exit and increased T cell retention [133,134,135]. While undoubtedly in our
data set the relative contribution from non-HEV dependent T cell entry increased as the
overall HEV-dependent contribution decreased, our data is consistent with this earlier
work measuring thoracic duct T cells in irradiated and nude animals which showed that
density of T cells in LNs influences T cell retention [133,134,135]. Further, this data
suggested that since endogenous T cell populations are quite low in LNs of FtDKO
mice, T cells that enter LNs of FtDKO mice would be retained longer relative to T cells
that enter LNs of WT mice since T cell density is up to 95% higher in LNs of WT mice.
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Memory T cells are significantly impaired in trafficking to LNs of FtDKO mice

Since exit rates of naïve and memory T cells were similar in our study, we tested
our second hypothesis that memory T cells were selectively homing to the LNs of
FtDKO mice. We transferred bone fide Thy1.1+ naïve or memory CD8 T cells that were
specific for the GP33-41 peptide of LCMV into WT or FtDKO Thy1.2+ recipient mice. As
before, both populations of Thy1.1+ CD8 T cells were CD62Lhigh and either CD44low
(naïve, antigen-inexperienced), or CD44high (memory, antigen-experienced).
Additionally, since these T cells were derived from WT mice, they retained the ability to
express fucosyltransferases following activation and make sLex bearing selectin ligands,
and could therefore potentially interact with E- or P-selectin expressed on HEVs of both
WT and FtDKO mice. Contrary to our hypothesis, transfer of memory CD8 T cells into
FtDKO mice also revealed a profound impairment in homing to LNs (Figure 3.6). While
in both WT and FtDKO mice, the majority of transferred memory T cells migrated to the
bone marrow and spleen, the remaining memory CD8 T cells preferentially homed to
the LNs in WT mice with very few cells homing to the LNs in FtDKO mice (51% WT vs.
2% FtDKO). In contrast, in the FtDKO mice, the memory T cells that did not home to
bone marrow or spleen preferentially homed to the lung and liver (89% FtDKO).
These data strongly argue that overall, memory T cells remain significantly
impaired in homing to the LNs of FtDKO mice compared to WT mice (Figure 3.6B, C).
Further, they suggest memory T cells also require selectin ligand expression by HEVs
for efficient homing to LNs. However, despite significant reductions in the total number
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of T cells that homed to the LNs of FtDKO mice, our analysis also revealed that
comparing memory versus naïve T cell populations, the small population of transferred
T cells that did migrate to LNs in FtDKO mice were more likely to be memory T cells
compared to WT mice (Figure 3.6E). Specifically, in WT mice we observed about a 3:1
preferential homing of naïve to memory T cells in LN, while in FtDKO mice we observed
no preferential homing of naïve T cells (Figure 3.6D, E). In fact, the frequency of
memory T cells was slightly increased in the FtDKO mice (Figure 3.6E). Stated another
way, these data suggest that entry of T cells into the LN via the non-HEV dependent
pathway (i.e. the afferent lymph) may be similar for naïve and memory T cells, while
HEV dependent entry strongly favors naïve T cells, even when memory T cells are
CD62Lhigh.

Memory T cells show increased homeostatic proliferation and accumulation in FtDKO
mice

Our data indicated that memory T cells were not preferentially retained in LNs
compared to naïve T cells, and also showed memory T cells did not preferentially
migrate to LNs of FtDKO mice. However, despite significant impairment in migration of
both naïve and memory T cell populations to LNs, the ratio of transferred memory T
cells was higher in FtDKO mice compared to WT mice. Since T cell populations are
substantially reduced in FtDKO LNs, our studies examining T cell exit suggested that
the few T cells that entered the low T cell density LNs of FtDKO mice would be retained
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longer at these sites. We therefore proposed an alternate hypothesis that memory T cell
populations that entered and exited LNs of FtDKO mice would show increased
homeostatic proliferation, and memory T cells would preferentially accumulate in LNs
over time.
To test this, we labeled P14xThy1.1+ memory CD8 T cells with CFSE and
transferred them into WT and FtDKO mice. Three weeks later we isolated organs from
recipient mice and assessed proliferation by CFSE dilution. As shown in Figure 3.7,
memory T cells transferred into FtDKO mice show greater homeostatic proliferation
compared to memory T cells transferred into WT mice (Figure 3.7A). Moreover, we also
observed that significantly more memory T cells were found in LNs of FtDKO mice at
day 21 compared to day 1 (Figure 3.7B). As before, the majority of transferred memory
T cells were located in bone marrow and spleen of WT and FtDKO recipient mice
(~88%). Of the remaining transferred cells, a greater fraction of memory T cells were
found in the LNs of FtDKO mice at day 21 compared to day 1 after transfer (Figure
3.7B). Whereas, day 1 after transfer into recipient mice, only 2% of transferred memory
T cells were found in LNs of FtDKO mice, by day 21 the percentage of memory T cells
observed in LNs increased more than 15-fold, to 35% (Figures 3.7B and 3.6B). Taken
together, these data suggest that memory T cells are enriched and remain abundant in
the LNs of FtDKO mice, despite severely impaired trafficking to LNs, as a consequence
of several mechanisms of T cell homeostatic maintenance, including longer retention in
low cell density LNs and increased homeostatic proliferation.
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Discussion

The generation of effective immune responses is critically dependent on
encounters between re-circulating T cells and their specific antigens, which primarily
occur in secondary lymphoid organs. One of the defining characteristics of the immune
system is the constant movement of constituent cell populations, including T cells and
dendritic cells (DCs) through SLOs, where a highly efficient filtration and surveillance
system are optimized for the capture of antigens and appropriate antigen presentation
[136,137,138]. Further, in contrast to naïve T cells, memory T cells respond more
rapidly to specific antigen, based on both quantitative increases in their starting
population, and qualitative differences in effector responses including rapid cytokine
secretion [139].
In this study, we present evidence that FtDKO mice, that are incapable of
synthesizing sLex bearing-selectin ligands, show significant enrichment of endogenous
CD44high effector/memory T cell populations in LNs and MALT such as O-NALT (Figure
3.1). When we infected FtDKO mice with LCMV to track Ag-specific CD44high CD8 T cell
responses in LNs, we show similar responses in blood and spleen of mice at day 8, but
Ag-specific CD44high CD8 T cells were reduced in LNs (Figure 3.2). Thus, although Agspecific CD8 T cells increased significantly in LNs of FtDKO mice at day 8 compared to
naïve FtDKO mice, selectin ligands were required for efficient Ag-specific CD8 T cell
trafficking and expansion in LNs. These data show for the first time that Ag-specific T
cell responses remain compromised in LNs following viral infection of these mice, even
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though these mice show similar kinetics of viral clearance [60].
In contrast, to our observations at day 8 following viral infection, we observed
that at day 60 p.i. FtDKO mice demonstrated abundant Ag-specific CD8 T cell
responses both in spleen and LNs (Figure 3.3). While total CD8 T cells remained
substantially reduced in LNs of FtDKO mice, the higher frequencies of Ag-specific
memory CD8 T cells in the LN compensated for the overall low T cell numbers and
particularly low CD44low naïve T cell population (Figure 3.3). These data suggest that
selectin ligands are not required for efficient localization of Ag-specific memory CD8 T
cells in LNs of immune mice.
We can recapitulate a similar increase in the percentage of CD44high T cells in LN
by treating WT mice with anti-CD62L, which substantially reduced LN T cell numbers by
blocking entry of new lymphocytes (Figure 3.4). Our analysis of T cell exit rates from LN
revealed no significant differences comparing naïve and memory T cells (Figure 3.5).
While these data contrast with a recent study examining in vivo CD44high endogenous
CD4 T cell populations using Kaede-Tg mice, several differences in the two studies
must be considered [132]. Firstly, we examined memory T cells of known antigen
specificity, while the Tomura et. al study examined endogenous CD44high T cells. When
we examined endogenous CD44high T cell populations, we also observed stable
numbers of this population, while naïve CD44low T cell numbers plummeted (Figure 3.4).
In our experiment, this could be due to continued entry of CD62Llow CD44high T cells,
slower exit of the CD44high population, or conversion of CD44low to CD44high T cells.
However, since we cannot determine whether these CD44high cells have recently
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encountered antigen, we cannot conclude that activated/memory T cells not exposed to
specific antigen were retained for longer periods based on these data. We therefore
examined bona fide Ag-specific memory T cells, where analysis of egress experiments
suggested that naïve T cells do not exit faster than memory T cells (Figure 3.5). Also,
while our analysis focused on CD8 T cells, the Tomura et al study focused on CD4 T
cells, which interact with a limited population of Ag-presenting cells expressing MHC
class II. Since memory CD4 T cells also show differences in survival and maintenance
compared to memory CD8 T cells, it is possible that memory CD4 T cells are indeed
retained longer in LN, as this study concluded, whereas memory CD8 T cell retention is
regulated differently [132,140].
Importantly, T cell density influences T cell exit rates from the LN. Our data
suggested that exit rates slowed as T cell density decreased (Figure 3.5). A previous
study suggested that T cells that enter LNs with many cells exit faster (ie shorter
residence time), while T cells that enter LNs with fewer cells, exit slower (ie longer
residency times) and our study examining Ag-specific naïve and memory T cells is
consistent with this study [135]. Further, when we examined memory T cell trafficking
into the LNs of FtDKO mice, we discovered that both naïve and memory T cells were
significantly impaired in homing to the LNs of FtDKO mice following adoptive transfer
(Figure 3.6). Thus the enrichment of memory T cells in the LNs of immune FtDKO mice
is unlikely to be due to significantly increased selectin-independent entry of memory T
cell populations into LNs.
The distribution of memory T cells in different organs will be different at different
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time-points since T cell migration is a very dynamic process dependent on the
expression of several adhesion molecules and chemotactic responses [141,142]. Our
experiments examining day 1 post-transfer showed that for both WT and FtDKO mice, a
significant fraction of memory T cells homed to the bone marrow and spleen (Figure
3.6). These results are consistent with several studies that have demonstrated that
memory T cells preferentially reside in the bone marrow where they undergo
homeostatic proliferation or proliferative renewal due to IL-15 maintenance signals
[105,123,143,144]. In contrast to WT mice, where the majority of the remaining
CD62Lhigh memory T cells homed to the LNs, most of the transferred memory T cells
were located in non-lymphoid organs in FtDKO mice (Figure 3.6B). We have recently
demonstrated that naïve T cells also preferentially re-distribute to non-lymphoid organs
such as lung in FtDKO mice [130]. We conclude from these studies that naïve, effector,
and memory CD8 T cell populations all show dependence on the expression of selectin
ligands for homing to LNs. However, we also observed that frequencies of
effector/memory (CD44high) T cells were consistently enriched in FtDKO mice, except at
day 8 when both WT and FtDKO showed similarly high proportions of CD44high CD8 T
cells of 60-90% (Figure 3.2).
Even though entry of memory T cells into LN was significantly impaired, the few
T cells that entered LNs of FtDKO mice, were more likely to be memory T cells
compared to LNs of WT mice, where naïve T cells preferentially homed (Figure 3.6).
Since these memory T cells entered LNs with very low T cell density in FtDKO mice, we
considered that longer retention in these organs could trigger greater homeostatic
77

proliferation, and our observations confirm this hypothesis (Figure 3.7). In lymphoid
organs, DCs and stromal cells such as fibroblastic reticular cells (FRCs) form a complex
three-dimensional meshwork through which T cells and other lymphocytes must travel
[137]. T cells that enter the depleted LNs of FtDKO mice could undergo lymphopeniainduced proliferation in the T cell zone if retained for a sufficient length of time at these
locations. However, antigen-independent T cell proliferation occurs more slowly than
antigen-driven proliferation and we were uncertain if the retention times in LN would be
sufficient for lymphopenia induced proliferation to occur. Additionally, most memory T
cells were located in bone marrow and spleen, major sites of memory T cell
proliferation, and we observed no defects in migration to these locations following
transfer into FtDKO mice [123]. Nonetheless, our data clearly demonstrated that
memory T cells divided more when transferred into fucosyltransferase deficient mice
(Figure 3.7). Thus, we suggest that the enrichment of memory CD8 T cells in LNs of
FtDKO mice compared to WT mice is due to several homeostatic maintenance
mechanisms. These include increased entry of memory T cells via non-HEV dependent
pathways (afferent lymphatics) compared to HEV dependent entry which favors naïve T
cells, slower exit of T cells from LNs with low T cell density, and increased homeostatic
proliferation of T cells. Together, these mechanisms enable abundant populations of
memory T cells to reside in lymph nodes and mucosal associated tissues of mice
lacking a critical glycosylation-dependent determinant of cell adhesion molecules, even
though migration of naïve, effector, and memory T cells to these critical secondary
lymphoid organs, is severely compromised.
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Materials and Methods

Mice and Immunizations

Fucosyltransferase -IV and -VII double knockout (FtDKO) mice backcrossed at least 9
generations to C57BL/6 were originally generated by Dr. John Lowe [62]. Mice were
obtained from the Consortium for Functional Glycomics (Scripps Research Institute, La
Jolla, CA) and originally bred in-house as homozygous double knockouts, but breed
poorly, and are currently maintained as heterozygous breeding pairs and genotyped by
PCR. Transgenic P14xThy1.1 mice were provided by Dr. Rafi Ahmed (Emory Vaccine
Center, Atlanta, GA) and bred in-house. C57BL/6 (WT) mice were purchased from The
Jackson Laboratory. Memory P14xThy1.1 chimeric mice were generated by adoptive
transfer of 5x105 total splenocytes from transgenic P14xThy1.1 mice into C57BL/6
recipients and infected with 2x105 pfu LCMV-Armstrong. FtDKO and C57BL/6 wildtype
control mice were immunized intraperitoneally (i.p) with 2x105 pfu LCMV-Armstrong. All
mice were maintained under specific pathogen-free conditions at the University of
Tennessee in accordance with IACUC guidelines and used at age 2 to 6 months.

Naïve and Memory Cell Trafficking

Where indicated, MACS (Miltenyi Biotech, Auburn, CA) purified naïve and memory
P14xThy1.1 CD8 T cells (1-2x106) from the spleen were adoptively transferred into WT
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or FtDKO recipient mice (Thy1.2). Naïve or memory cells were labeled with
carboxyfluorescein succinimidyl ester (CFSE) in order to differentiate transferred naïve
and memory P14xThy1.1 CD8 T cell populations, or to examine homeostatic
proliferation. Equal numbers of Ag-specific CD8 T cells were injected intravenously
(i.v.) via tail vein into age-matched recipient mice. For anti-CD62L experiments to
measure exit rates, equal numbers of naïve and memory T cells were adoptively
transferred into recipient mice, and one day later 100µg of MEL-14 (α-CD62L) blocking
antibody (BioXcell, W. Lebanon, NH) was injected i.v. Organs were collected before
treatment and 8, 24, and 48 hours after treatment, and exit rates were calculated as
indicated below.

Organ Harvest, Flow Cytometry, and Histology

At indicated time points mice were sacrificed, organs were perfused with 5ml cold PBS,
and all organs were harvested for processing as previously described [85,122]. Briefly,
for lung and liver, perfused organs were minced, incubated with HBSS+ 1.3mM EDTA
solution for 30 minutes at 37oC, re-suspended in 225U/ml type I collagenase for 60
minutes at 37oC, and cells were centrifuged using a Percoll density gradient to isolate
lymphocytes from the parenchyma. Isolated lymphocytes were counted from all organs
and single cell suspensions were stained with DbNP396-404 or DbGP33-41 tetramers,
provided by the NIH Tetramer Facility (Atlanta, GA), and mAbs (CD8, CD4, CD44,
CD62L, Thy1.1, Thy1.2) [145]. Total number of cells in bone marrow was calculated by
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multiplying the number of cells from two femurs x 7.9 [123]. Monoclonal antibodies were
purchased from BD (La Jolla, CA). All samples were run on a FACSCalibur (BD
Biosciences) and analyzed with FlowJo software (Treestar).

For transfer studies, to calculate the proportions of transferred cells in different organs,
total, naïve, or memory Thy1.1+ CD8+ T cells in 9 indicated organs were enumerated.
The number of transferred memory cells in each organ was then divided by the memory
cell populations in all examined organs as depicted by a pie graph. Statistical
significance was determined using unpaired student t tests where *indicates p<0.05, **
p<0.01, and *** p<0.001.

Modeling of naïve and memory exit rates

Our analysis is based on the following, simple model of T cell inflow into a lymph node,
(1)
where

is the density of a given CD8+ cell type, naive or memory, at time ,

the immigration rate of these cells into a given LN and
that the drug treatment results in
implies that
at some time ,

is

is the egress rate. Assuming

being reduced to near zero values, Equation (1)

will undergo an exponential decay process. That is, given a cell density
, the density of cells at time
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is simply,

(2)
Taking the log of both sides of Equation (2) yields,

Thus, we can estimate

at different time points by fitting a linear regression model to

the log transformed data at times

and

. Statistical tests for differences in

as a

function cell type, tissue, and time period using an F-test. Specifically, for the Early
treatment

and

and for the Late treatment

and

.

Regression fits to the log transformed data and F-statistic calculations and comparisons
were done in R 2.11 using the the lm and anova functions which are part of the R's
standard statistical package stats.
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Figure 3.1. Increased frequency of CD44high T cells in LNs of FtDKO mice.
Lymphocytes were isolated from organs of WT and FtDKO mice. Cells were stained
with CD4, CD8, and CD44 mAbs. Numbers indicate percentage of CD44high CD8 T
cells. A, Representative FACS analysis of indicated organs from WT or FtDKO mice.
B, Enumeration of total CD8 T cells and CD44high CD8 T cells in indicated organs. C,
Percentage of CD44high CD8 T cells in indicated organs. Data was collected from n=6
WT and n=6-7 FtDKO in two independent experiments. For O-NALT, one experiment is
shown where cells were pooled from n=4 mice/group. The unpaired Student t test was
used to compare groups. (*p<0.05, ** p<0.01, and *** p<0.001)
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Figure 3.2. Similar frequency of day 8 Ag-specific effector CD44high CD8 T cells, but
reduced number in LNs of FtDKO mice. WT or FtDKO mice were infected with 2x105
pfu LCMV-Armstrong i.p. and lymphocytes were isolated on day 8. Single cell
suspensions from indicated organs were stained with CD8, CD44, and DbNP396-401
tetramer. Gating on CD8 T cells, numbers in FACS panels indicate percentage of Agspecific CD8 T cells in organs. A, Histogram showing expression of CD62L on CD8 T
cells on day 0 and 8 in WT and FtDKO mice. B, Representative FACS analysis of
PBMCs and LNs on day 8 p.i. C, Enumeration of Ag-specific and total CD8 T cells on
day 8. D, Ratio of Ag-specific CD8 T cells, comparing FtDKO vs. WT mice in indicated
organs. E, Percentage of CD44high CD8 T cells in indicated organs. Data was collected
from n=2 WT and n=3 FtDKO. (* p<0.05, ** p<0.01, and *** p<0.001)
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Figure 3.3. Ag-specific memory CD44high CD8 T cells are abundant in LNs of FtDKO
mice. WT or FtDKO were infected with LCMV-Armstrong i.p. and lymphocytes were
isolated on day 60 p.i. Single cell suspensions were stained with CD8, CD44, and
DbGP33-41 tetramer. Gating on CD8 T cells, numbers in FACS panels indicate percent
of Ag-specific CD8 T cells in organs. A, Representative FACS analysis Of PBMC and
LNs on day 60. B, Enumeration of Ag-specific and total CD8 T cells on day 60. C,
Ratio of Ag-specific CD8 T cells, comparing FtDKO vs. WT mice in indicated organs. D,
Time-course following LCMV-Armstrong infection of DbNP396-401-specific CD8 T cells,
DbGP33-41-specific CD8 T cells, CD44high CD8 T cells, and total CD8 T cells comparing
spleen and CLN. E, Percentage of CD44high CD8 T cells in organs. Data was collected
from n=4 WT and n=4 FtDKO. (*p<0.05, ** p<0.01, *** p<0.001, and ns, not significant)

88

89

Figure 3.4. Ratio of memory T cells increases in WT mice following inhibition of Lselectin mediated entry. WT mice were given 100ug of anti-CD62L blocking antibody
i.v. and single cell suspensions were prepared from isolated organs at 0, 24 or 48 hours
post-treatment, and stained with CD4, CD8 and CD44 mAbs. A, Enumeration of total
CD8 T cells, CD44high CD8 T cells, and CD44low CD8 T cells over 48-hour time course.
B, Percentage of CD44high CD8 T cells at 0, 24, and 48 hours. Data was collected from
n=2-6 mice for each time-point. (*p<0.05, ** p<0.01, and *** p<0.001)
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Figure 3.5. Exit rates of naïve and memory CD8 T cells from LN are similar, but
residency time in the LN is density-dependent. CD8 T cells were purified from naïve
Thy1.1xP14 Tg mice (CFSE+) or immune (day 200 p.i.) Thy1.1xP14 Tg chimeric mice
(CFSE-), transferred into WT Thy1.2 recipient mice, and 18 hrs later mice were given
100ug anti-CD62L blocking antibody i.v. LNs were isolated 0, 8, 24, and 48 hours post
treatment.. A, Experimental design. B, Naïve and memory CD8 T cells were isolated
from indicated organs and egress rates determined comparing early (0 to 8 hrs) and late
(24 to 48-hrs) time points when total T cell density of LNs changed significantly. Data
represents n=3 mice for each time point. Open symbols show memory T cells, and filled
symbols show naïve T cells.
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Figure 3.6. Memory T cells are significantly impaired in trafficking to LNs of FtDKO
mice. CD8 T cells were purified from naïve Thy1.1xP14 Tg mice (CFSE+) or immune
(day 200 p.i.) Thy1.1xP14 Tg chimeric mice (CFSE-), transferred into WT or FtDKO
recipient mice, and recipient mice were sacrificed 18 hours later. Thy1.1 was used to
differentiate endogenous from transferred T cell populations in indicated organs. A,
Experimental design. B, Pie charts showing the distribution of memory CD8 T cells in
WT and FtDKO recipient mice in 9 indicated organs. The smaller pie charts show the
distribution of remaining (~12%) memory CD8 T cells not in bone marrow or spleen
(PBMC, liver, lung, CLN, MedLN, ILN and IngLN). C, Enumeration of transferred naïve
and memory CD8 T cells in CLN. D, Representative FACS analysis of CLN and PBMC.
Numbers indicate the percentage of memory (CFSE-) and naïve (CFSE+) Thy1.1 CD8 T
cells in WT and FtDKO mice. E, Bar graphs showing percentage of naïve or memory
Thy1.1+ cells comparing WT and FtDKO mice. Data was collected from n=5 WT and
n=6 FtDKO from two independent experiments. (*p<0.05, ** p<0.01, and *** p<0.001)
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Figure 3.7. Memory T cells show increased homeostatic proliferation and accumulation
in FtDKO mice. P14x Thy1.1+ CFSE+ memory CD8 T cells were transferred into WT or
FtDKO recipient mice, and 21 days later recipient mice were sacrificed. Thy1.1+ CFSE+
memory CD8 T cells were enumerated in organs and CFSE dilution analyzed. A,
Representative histograms showing CFSE dilution of transferred memory cells in
indicated organs at 21 days. Number indicates percentage of undivided cells in each
panel. Bar graphs show percentage of undivided memory CD8 T cells in WT compared
to FtDKO mice. B, Pie charts showing distribution of memory CD8 T cells in WT and
FtDKO recipient mice in 9 indicated organs at 21 days post-transfer. The smaller pie
charts show the distribution of remaining memory CD8 T cells (~13%) not in bone
marrow or spleen (PBMC, liver, lung, CLN, MedLN, ILN and IngLN). Data was collected
from n=2 mice in each group. For the FtDKO group, one animal was Ft-VII -/- / Ft-IV +/-.
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Table 3.I.

Treatment
Early
Late
Late ILN

Rate (h-1)

SE

t-value

p-value

0.1195

0.015360

-7.782

0.0440
0.0082

0.005912
0.010240

-7.450
-0.806

< 10-10
< 10-10

Table I: Estimates of T-cell egress.
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One of the fundamental properties of the adaptive immune system is the ability to
direct T cells and APCs in a site-specific manner so that an effective immune response
can be elicited. This interaction of T cells and APCs typically occurs in secondary
lymphoid organs, where conditions are optimized for rare Ag-specific T cells to come in
contact with APCs in order to become activated (Figure 4.1). Upon activation, the
activated T cells can proliferate, differentiate, leave the secondary lymphoid organ, and
enter the target organ to degranulate after TCR triggering and release granzyme B or
perforin (CD8 T cells) or recruit additional immune cells (CD4 T cells) [146]. At the peak
of the CD8 T cell response, 90% to 95% of effector T cells die leaving a pool of cells
that differentiate into memory T cells that can act as sentinels for possible re-infection
[146]. With an understanding of the molecular mechanisms that govern cell migration,
we can begin to employ successful therapeutic strategies to ameliorate human disease
caused by misguided cell migration.

Naïve T cells accumulate in lung while memory T cells accumulate in LNs

In uninfected, specific pathogen free mice, the majority of T cells are naïve T
cells (CD44low) with a smaller number of effector or memory T cells (CD44high). Memory
T cells, which are antigen experienced, can establish primary residency in secondary
lymphoid organs (central memory T cells) or peripheral organs (effector memory T
cells), however both subsets have the capacity to exert effector function (i.e.
degranulate or help recruit additional immune cells). In WT mice, naïve T cells are
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found preferentially in secondary lymphoid organs while memory T cells can be found
predominantly in bone marrow and spleen. When studying the distribution of T cells in
FtDKO mice, it is clear that the loss of selectin ligands has a drastic effect on T cell
location. There is a severe reduction in the number of T cells that enter LNs in FtDKO
mice, but naïve T cells are present in the spleen and blood. One surprising observation
was that these mice demonstrate an increased numbers of naïve T cells in the lung. To
initially investigate the reason for increased naïve T cells in the lung, we performed an
analysis of lung sections and found no evidence of iBALT. In contrast, CCR7 KO mice,
which also show defective migration to LNs, show evidence of iBALT [89]. Additionally,
we made another observation in uninfected FtDKO mice where we observed that the
frequency ofCD44high memory T cells was higher in the LNs compared to WT. These
results raised a few questions that we wanted to investigate. Why were we observing
more naïve T cells in the lung of FtDKO mice? Why were there greater frequencies of
“memory” CD44high T cells in the LNs of uninfected FtDKO mice?

Generation of effector and memory T cells and adoptive transfer

To address these questions, we assayed the distribution of T cells during a viral
response using the LCMV-Armstrong model. In the mouse, the number of Ag-specific
naïve T cells for a specific epitope is quite low (100-200 epitope specific cells), while the
number of Ag-specific memory T cells is significantly higher in an immune host (500,000
epitope specific cells) [149]. However, both T cell populations require interaction with
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APCs for activation and this typically occurs in LNs and other secondary lymphoid
organs. Upon interaction with TCR displaying cognate antigen, naïve T cells become
activated and initiate proliferation. Following proliferation, the newly differentiated
effector T cells begin to secrete effector cytokines (i.e. IFNg) and or display killer
function. In contrast, memory T cells can immediately secrete effector cytokines and or
display killer functions following TCR engagement and also begin to proliferate [150]. In
addition to differences in activation and early effector function, naïve and memory T
cells preferentially localize in different sites. It has been shown that naïve T cells
primarily migrate between secondary lymphoid organs because of high expression of Lselectin. On the other hand, memory T cells may or may not express L-selectin and
also express surface receptors that facilitate entry to non-lymphoid organs such as the
skin via the skin homing molecule CLA [6].
In our experiments, Ag-specific T cells were activated and expanded in FtDKO
mice, however T cell numbers were reduced in LNs and lung compared to WT mice at
day 8 post infection. This result corroborates other studies suggesting that the
upregulation of fucosyltransferase –IV and –VII in activated T cells is important to
access the inflamed lung [90]. After the infection was cleared and memory established,
we found that total T cell numbers in the FtDKO lung were still reduced. However, Agspecific memory CD8 T cell numbers in the LNs were similar to WT. This suggested
that unlike naïve CD8 T cells and Ag-specific effector CD8 T cells, Ag-specific memory
CD8 T cells potentially showed no defects in either entering the LNs, or were not exiting
the LNs as rapidly as naïve T cells (i.e. they were being preferentially retained).
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To determine whether naïve T cells homed to the lungs of FtDKO, we performed
an adoptive transfer of naïve and central memory CD8 T cells. By transferring a similar
ratio of bona fide Ag-specific naïve and Ag-specific central memory CD8 T cells of the
same peptide specificity into recipient WT and FtDKO mice, we could directly test the
distribution of naïve versus memory T cell populations. In the lungs of FtDKO recipient
mice, we found that transfer of both naïve and central memory T cell populations
resulted in greater numbers in the lung when T cells could not enter LNs. If we had
performed an additional experiment using effector memory T cells, we predict that
effector memory T cells would preferentially accumulate in the lung as well, since
effector memory T cells preferentially home to peripheral organs [6]. To further
understand the observation of increased naïve T cells in the lung, we performed
additional transfer experiments in WT mice where we blocked LN access by either
treating CD8 T cells with a Gαi signal disruptor (PTx) or treating recipient mice with antiCD62L antibody. These experiments resulted in more T cells in the blood and more T
cells in non-lymphoid organs, like the lung. Performing the converse experiment of
disrupting T cell exit from the lymph node with the S1P1 agonist, FTY720 resulted in
fewer cells in the blood and non-lymphoid organs. These data supported our hypothesis
that if entry to LNs is disrupted, T cells will re-distribute and accumulate in non-lymphoid
organs (Figure 4.2).
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Entry to LN and exit from LN is similar in both naïve and memory T cells

As mentioned previously, Ag-specific memory CD8 T cells were enriched in the
LNs of FtDKO mice. To determine whether memory T cells entered LNs via selectin
ligand independent mechanisms, we transferred WT naïve and central memory T cells
into WT and FtDKO mice. We found that both subsets were significantly reduced in the
LNs of FtDKO mice, implying that both naïve and memory T cells require selectinselectin ligand interactions to optimally enter LNs. If we had performed an additional
experiment, by isolating naïve and memory T cells from FtDKO mice, which cannot
express selectin-ligands, and transferring them into WT or FtDKO recipient mice, we
might observe different results. Naïve T cells which do not express fucosyltransferase –
IV and –VII would likely not have altered trafficking patterns in recipient WT mice
because the environment in the WT mouse would be similar. However, transferred
memory T cells into WT recipients would likely be affected by the absence of E- and Pselectin ligands on the transferred T cell and as a consequence may demonstrate
reduced trafficking to peripheral organs.
Since memory CD8 T cells were not entering the LNs using selectin ligand
independent mechanisms, these data suggested that naïve and memory CD8 T cells
might have different retention rates within the LNs. To determine the possibility of
different exit rates, we transferred naïve and central memory CD8 T cells into recipient
WT mice and treated the recipient mice with anti-CD62L to prevent new cells from
entering the LN. We observed no statistical differences in naïve versus memory T cell
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egress. However, in a recent report, the data suggested that naïve CD4 and memory
CD4 T cells have different retention rates, possibly due to CD4 T cell interaction with
MHC-II and CD8 T cell interaction with MHC-I [48]. In our study, we found that both
populations of CD8 T cells exited similarly, but the rate of their exit was dependent on
the density of cells in the LN. As T cell density decreases, T cells show longer retention
in LNs.
These data prompted us to hypothesize that memory cells that do move through
the low density LN may undergo increased homeostatic proliferation. Many studies
have shown that T cells can proliferate via emptiness induced homeostatic proliferation
as well as Ag-driven proliferation [147,148]. In emptiness induced homeostatic
proliferation, it has been found that as naïve CD8 T cells divide, they begin to express
memory T cell markers such as CD44 and CD122 [147]. Of note, the cells that
underwent emptiness induced homeostatic proliferation were capable of producing
IFNg, but the levels of IFNg were not as high as the levels produced by T cells that
underwent Ag-driven proliferation [147]. To determine whether T cells showed
increased homeostatic proliferation in FtDKO mice, we adoptively transferred CFSE
labeled memory T cells into FtDKO mice and assayed proliferation several weeks later.
We found increased proliferation of memory T cells in FtDKO mice compared to WT.
These data suggested that although migration of memory T cells into selectin ligand
deficient LNs is greatly impaired, the small number of memory T cells that do enter, will
undergo substantial proliferation, and subsequently we observe an increase in the
frequency of the memory T cells in the LNs (Figure 4.3). However, one other important
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factor to consider is that naïve T cells likely undergo increased proliferation in FtDKO
mice as well and that the increased frequency of CD44high “effector/memory” cells that
we observed in the LNs of uninfected FtDKO mice might also be due to this emptiness
induced proliferation [147].

FtDKO as tools for studying T cell trafficking

By using FtDKO mice, we were able to perform elegant experiments that allowed
us to identify similarities and tease apart differences between naïve and memory T cell
trafficking. We discovered that defects in T cell trafficking to LNs results in
accumulation of naïve T cells in non-lymphoid organs of FtDKO mice and also that
memory T cells accumulate in LNs due to increased homeostatic proliferation. These
two previously unknown phenotypes in FtDKO mice revealed that naïve and memory T
cells display unique mechanisms for compensating for selectin ligand deficiency. Using
these mice as a tool to understand the impact of altered trafficking may help treatments
for immune cell trafficking related diseases become more readily available.
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Figure 4.1. Effector T cell trafficking. Upon infection, cytokines will induce the
upregulation of E- and P-selectin on epithelial cells. APCs from the site of infection will
migrate towards the draining lymph node and interact with T cells. When the antigen
specific T cell recognizes its cognate antigen, it will begin to upregulate
fucosyltransferase –IV and –VII (to modify glycoproteins, PSGL-1 or CLA-4), CD44, and
various chemokine receptors (i.e. CCR4 and CCR9), downregulate CD62L and CCR7
and proliferate. Activated T cells can then migrate back to the site of infection in order
to clear antigen.
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Figure 4.2. Naïve T cell trafficking patterns. A) Naïve T cells primarily enter LNs from
the blood (red arrow) where they can engage adhesion molecules on the HEV. After
transiting through the LN environment, naïve T cells will enter the efferent lymphatics
(green arrow), enter the thoracic duct, and finally move back into blood circulation.
Once in the blood, naïve T cells can transit through non-lymphoid organs (i.e. lung).
Some naïve T cells will bypass HEVs and continue to travel though the blood to briefly
reside in non-lymphoid organs. B) If entry to LN is blocked (selectin ligand deficiencies
- FtDKO, Gαi signaling –PTx, or anti-L-selectin antibody), a greater number of naïve T
cells will remain in the blood and enter non-lymphoid organs. C) If exit from LN is
blocked (S1P1 agonist – FTY720), naïve T cells will accumulate in the LNs and as a
consequence reduce the number of naïve T cells in the blood and non-lymphoid organs.
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Figure 4.3. Central memory T cell trafficking patterns. A) Central memory T cells
preferentially home to secondary lymphoid organs (i.e. lymph node) via the blood (red
arrow) where they can engage adhesion molecules on the HEV. A small number of
central memory T cells can also enter lymph nodes through the afferent lymphatics
(non-HEV) route. The central memory T cells can then migrate through the LN (short
duration) and enter into the efferent lymphatics (green arrow), enter the thoracic duct,
and finally move back into blood circulation. Once in the blood, central memory T cells
can transit through non-lymphoid organs (i.e. lung). Some central memory T cells will
bypass HEVs and continue to travel though the blood to briefly reside in non-lymphoid
organs. B) If entry to lymph node is blocked (selectin ligand deficiency – FtDKO or antiL-selectin antibody), a greater number of naïve T cells will remain in the blood and enter
non-lymphoid organs. The small number of cells that do enter the LNs via the afferent
lymphatics, will experience a longer than normal residency time, due to decreased
density, where they will undergo increased proliferation.
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